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Abstract

Isometric handgrip (IHG) training lowers resting arterial blood pressure (BP) in older,
normotensive adults and it has been proposed that repeated exposure to oxidative stress,
via IHG-induced ischemia-reperfusion (IR), could be an underlying mechanism. The
objectives were to quantify the IHG neurovascular stimulus, determine if this IHG
protocol elicits systemic vascular effects, and compare the response of the IHG stimulus
to an IR cuff protocol. Vascular reactivity, assessed via flow-mediated dilation (FMD)
and strain-gauge plethysmography (RVF), was determined prior-to and immediately-post
an IHG bout in the exercised arm, non-exercised arm, and after IR in the reperfused arm.
No significant differences were found in FMD or RVF after each of the three bouts.
These findings suggest that vascular reactivity remains unchanged in either limb, both in
response to an acute IHG bout and a complementary IR cuff protocol, indicating
oxidative stress may not be a part of the acute IHG stimulus.
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Chapter 1: Introduction & Literature Review
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1.1 Hypertension
1.1.1 Introduction
Cardiovascular disease (CVD) is recognized as the leading cause of death
worldwide (WHO, 2013). CVD is characterized by disorders of the heart and blood
vessels and includes coronary heart disease, cerebrovascular disease, elevated blood
pressure, peripheral arterial disease, rheumatic heart disease, congenital heart disease and
heart failure (WHO, 2013). Empirically, it is estimated that CVD was responsible for
17.3 million deaths worldwide in 2008 (WHO, 2013). Further, it is projected that this
rate will grow to almost 23.6 million deaths per year by 2030 (WHO, 2013). In Canada,
CVD is a leading cause of mortality in both males and females (Statistics Canada, 2009).
Economically, total costs relating to CVD in Canada were estimated to be $20.9 billion in
2005, with projections to $28.3 billion by 2020 (Theriault et al., 2010). Given the
widespread prevalence and projected increases, coupled with the economic burden of this
disease, the prevention and control of CVD is very important.
Although CVD is the leading cause of mortality worldwide (WHO, 2013) it is
considered a preventable disease through the modulation of a number of behavioural risk
factors. These behavioural risk factors include diet quality, physical activity status,
stress, tobacco use, alcohol consumption, body composition, blood pressure, and blood
cholesterol (PHAC, 2009). It has been estimated that these behavioural risk factors are
responsible for approximately 80% of CVD (WHO, 2013). Additionally, there are nonmodifiable risk factors, including age, gender, family history, ethnicity, and medical
history that also contribute to the development of CVD (PHAC, 2009). While the
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relative contributions of each of these factors is difficult to quantify, it appears that
hypertension (HT), or chronically sustained elevations of systolic and/or diastolic arterial
blood pressure (BP), accounts for approximately 7.5 million deaths worldwide each year
and is a leading modifiable risk factor for CVD (WHO, 2013).
1.1.2 Arterial Blood Pressure Regulation
Prior to discussing the pathophysiology of HT, it is important to understand basic
arterial BP control in a healthy physiological state. Efficient function of the
cardiovascular system requires the maintenance of adequate arterial blood pressure (BP)
during the cardiac excitation-relaxation cycle to allow for adequate perfusion of bodily
tissues (Herd, 1970). Arterial BP can be sub-divided into systolic (SBP) and diastolic
(DBP) components, which represent the different phases of cardiac contraction. SBP
occurs during the period of cardiac contraction and represents the pressure that the blood
exerts on the artery walls during ventricular systole (Herd, 1970). In contrast, DBP
occurs during the period between cardiac contractions and represents the pressure exerted
by the blood on vessel walls during cardiac relaxation and gives an indication of
peripheral resistance (Herd, 1970). In individuals with normal resting arterial BP,
measurements of pressure during systole average <120 mmHg, while measurements
during diastole average 80 mmHg (Chobanian et al., 2003).
Arterial BP is derived from the product of cardiac output (Q) and total peripheral
resistance (TPR). Q is the product of the rate of contraction of the heart (heart rate; HR)
and the volume of blood pumped per contraction (stroke volume; SV). TPR is the sum of
the resistance to blood flow provided by the peripheral vasculature within the entire
systemic circulation (Washburn, 1921). TPR is greatly influenced by changes in the
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radius of the peripheral vasculature through vasoconstriction or vasodilation. As such,
modulation of BP may occur through changes in Q, via HR and/or SV, and/or through
changes of the TPR within the system. These pressures are tightly controlled by a
number of innate pathways including neural, hormonal, vascular, and genetic BP control
mechanisms.
Innate Blood Pressure Control Mechanisms
Regulation of arterial BP is controlled through the coordinated efforts of neural,
hormonal, vascular, and genetic control mechanisms. These mechanisms function via
modulation of Q via HR and/or SV, as well as TPR, through alterations in vasodilation
and vasoconstriction of the vascular smooth muscle.
Neural Blood Pressure Control
Neurological control of BP functions predominantly through the integration of the
sympathetic (SNS) and parasympathetic nervous systems (PNS) within the autonomic
nervous system (ANS). In brief, sympathetic activation augments resistance to blood
flow, which raises arterial BP via increased TPR (Dampney et al., 2002), and also acts to
increase HR and force of myocardial contraction, which lead to increases in both Q and
BP (Dampney et al., 2002). In opposing fashion to the SNS, PNS stimulation leads to a
significant decrease in HR and a small decrease in cardiac contractility (Dampney et al.,
2002). The net neural effect on the cardiovascular system is dependent on the balance of
stimulation between these two systems.
Coordination of the SNS and PNS is controlled by a brain region known as central
command (CC), which sends information to the cardiovascular control center (CCC)
	
  

4	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

(Dampney et al., 2002; Eldridge et al., 1985). The CCC can be classified as an
integration center as it receives both ascending and descending information when
coordinating a response. CC is able to modulate the balance of the ANS through
innervation of the CCC in response to the added stress of exercise (Victor et al., 1995).
Additional sensory information is provided through signals received from arterial
baroreceptors, chemoreceptors, and muscle afferent receptors.
Arterial baroreceptors contribute to the regulation of arterial BP through afferent
feedback to the CCC (Lafranchi & Somers, 2002). These receptors, located in the heart,
pulmonary vessels, and throughout the arterial walls of the carotid artery, indirectly
monitor changes in arterial BP. As baroreceptors do not sense pressure, but the
conformational change in the vessel wall caused by pressure changes, they are classified
as stretch receptors (Angell-James, 1971). Afferent feedback allows the CCC to
modulate the relative contributions of the SNS and PNS to maintain arterial BP around a
homeostatic set point (Lafranchi & Somers, 2002). An increase in arterial BP triggers an
increase in the frequency of impulses sent from the baroreceptors to the CCC resulting in
increased PNS and decreased SNS activation (Lafranchi & Somers, 2002). Likewise, a
decrease in arterial BP triggers a decrease in the frequency of impulse generation from
the baroreceptors to the CCC resulting in increased SNS activation (Lafranchi & Somers,
2002).
The composition of metabolites within the circulating blood serves as a further
stimulus to arterial BP regulation mechanisms. Chemoreceptors, located within the
carotid and aortic bodies, sense changes in the partial pressure of oxygen (PaO2) and
carbon dioxide (PaCO2), as well as hydrogen ion (H+) concentrations, within the arterial
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blood (Prabhakar, 2000). These receptors send afferent feedback to the CCC to induce
SNS activation in response to reductions in PaO2, increases in H+ concentration, and
increases in PaCO2 (Prabhakar, 2000; Dampney et al., 2002). The resulting response
consists of vasoconstriction of the vascular beds, increasing TPR, coupled with increases
in ventilation in an effort to increase arterial BP.
Muscular afferent receptors function to regulate arterial BP in similar manner to
the receptors described above. Type III afferent receptors, or mechanoreceptors, sense
stretch and deformation due to pressure, whereas type IV afferents, or metaboreceptors,
sense changes in the muscular milieu (Leshnower et al., 2001). More specifically, type
IV receptors are stimulated by chemicals and metabolic by-products of muscle
contraction such as lactic acid, dipronated phosphate, potassium (K+), bradykinin,
serotonin, and adenosine (Leshnower et al., 2001). Information provided by these
receptors is processed in the CCC and the response is an alteration of the balance of the
SNS and PNS within the ANS, leading to changes in HR and arterial BP (Leshnower et
al., 2001; Pawelczyk et al., 1997).
Hormonal Blood Pressure Control
Certain hormones of the human body have a profound impact on the regulation of
an individual’s arterial BP. The most influential BP modulating hormones include the
catecholamines epinephrine (E) and norepinephrine (NE), acetylcholine (ACh), the reninangiotensin-aldosterone system (RAAS), arginine vasopressin (AVP), and atrial
natriuretic peptide (ANP). The coordinated efforts of these hormones, along with

	
  

6	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

vascular, neural, and genetic mechanisms, function to defend homeostatic arterial BP
levels.
The sympathetic nervous system is the distributor of the catecholamines E and
NE, which elicit various cardiovascular responses based on which receptor they bind to
and its location within the body. SNS nerve fibers form a synaptic junction with vascular
beds within a close proximity to effectively distribute these catecholamines. When the
SNS is stimulated it triggers the release of E and NE from the adrenal glands (Mannelli et
al., 1990). E is released directly into the systemic circulation, whereas NE is released
predominantly at the synaptic junction between the SNS nerve fiber and the vascular
beds, though a small amount does also reach systemic circulation (Mannelli et al., 1990).
E and NE regulate arterial BP through modulating both Q and TPR depending on specific
receptor binding (Mannelli et al., 1990).
There are two main types of receptors bound by E and NE, the α-adrenergic
receptors and the β-adrenergic receptors (Ruffolo et al., 1991). These are further subdivided based on location and mechanism of action. α-adrenergic receptors are divided
into α1-receptors, located within most sympathetic target organs, except the heart, and
α2-receptors, located within the membranes of the NE nerve endings within the synaptic
junction (Mannelli et al., 1990). β-adrenergic receptors are divided into β1-receptors,
located within the heart, kidneys, liver, and adipose tissues, and β2-receptors, located
within most sympathetic target organs (Mannelli et al., 1990). E’s binding to the αadrenergic receptors elicits a vasoconstrictory response, whereas it elicits a vasodilatory
response when bound to β-adrenergic receptors (Mannelli et al., 1990). NE binds to post-
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synaptic α-adrenergic receptors within the synaptic junction to elicit a vasoconstrictory
response in the target vascular beds (Ruffolo et al., 1991). Modification of the state of
smooth muscle contraction in the target vasculature regulates arterial BP through changes
in TPR.
The catecholamines also influence Q through changes in HR. This pathway is
mediated through second messenger cellular cascades initiated by cyclic adenosine
monophosphate (cAMP) (Opie, 2004). cAMP is produced through the stimulation of βadrenergic receptors by E within the cardiac cells, which then initiates cAMP-dependent
protein kinase A (PKA) (Krammer, 1988). PKA increases HR by accelerating the rate of
impulse generation at the sino-atrial (SA) node, as well as increasing diastolic filling
time, which increases arterial BP (Larsson, 2010).
The PNS can regulate arterial BP through distribution of ACh, a neurotransmitter
released from PNS nerve fibers (Dale et al., 1936). ACh regulates arterial BP through
binding to muscarinic receptors within the cardiac cell membrane and inhibiting adenyl
cyclase, which then inhibits elevated intracellular cAMP concentrations (Brodde &
Michel, 1999). A decrease in intracellular cAMP reduces calcium channel
phosphorylation, reducing the number of open calcium channels and inhibiting calcium
influx (Brodde & Michel, 1999). As sarcoplasmic reticulum (SR) calcium release is
dependent upon the influx of extracellular calcium, a process termed calcium-induced
calcium release (CICR), and SR calcium release provokes cardiac contraction, a reduced
influx depresses cardiac contractility, and therefore Q, leading to reduced arterial BP
(Fabiato, 1983).

	
  

8	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

ACh can also reduce arterial BP through decreases in HR. The release of ACh
can hyperpolarize the SA node, which increases the time required to reach the threshold
potential for excitation (Brodde & Michel, 1999). As such, there is a greater amount of
time between cardiac contractions, lowering HR, therefore lowering arterial BP.
The most important long-term arterial BP regulation system involves the
integration of the kidneys and adrenal glands, as well as a number of hormones and
enzymes, within the RAAS. The efficiency of this system stems from the effects it exerts
on both total blood fluid volume and vascular tone. The RAAS is initiated when renin, a
glycoprotein enzyme, is released via exocytosis from the kidneys (Vander, 1967). Renin
is then able to facilitate the conversion of angiotensinogen, a pro-hormone secreted by the
liver, to angiotensin I (Nguyen et al., 2002). Angiotensin I is considered an inactive form
of this protein and is further modified by the angiotensin-converting enzyme (ACE) into
angiotensin II, considered an active form (Donoghue et al., 2000). Angiotensin II is a
potent vasoconstrictor and, as such, will have a direct effect on arterial BP through
increases in TPR. Angiotensin II also triggers the release of aldosterone from the adrenal
cortex (Carey & Siragy, 2003). Aldosterone is a hormone that promotes fluid retention
through the conservation of sodium, which increases total blood fluid volume and,
therefore, arterial BP (Leutscher & Johnson, 1954).
An increase in arterial BP can induce stretching of the arterial walls within the
heart. Cardiac atrial cells release ANP in response to this stretch in an effort to reduce
arterial BP. ANP can decrease arterial BP via two different mechanisms. First, ANP
prevents vascular vasoconstriction through the inhibition of actin-myosin binding, which
dilates smooth muscle and reduces TPR (Potter et al., 2009). Second, by promoting
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diuresis and sodium excretion, ANP reduces total blood fluid volume, which can also
decrease arterial BP (deBold et al., 1981).
AVP, also referred to as anti-diuretic hormone, is released from the pituitary
gland in response to a decrease in arterial BP (Henderson & Byron, 2007). AVP
increases arterial BP via two mechanisms, which are similar, yet opposite, to that of
ANP. AVP can induce vasoconstriction of smooth muscle, increasing TPR and therefore
BP (Holmes et al., 2004). Further, AVP also influences fluid balance regulation.
Through binding to the adenylyl cyclase-coupled vasopressin receptor in the kidney,
AVP reduces urinary water excretion by promoting water reabsorption through the
collecting duct (Holmes et al., 2003; Nielsen et al., 1995). Increased water reabsorption
elevates blood fluid volume, which increases arterial BP.
Local Blood Pressure Control
Arterial BP can also be regulated by a number of locally released vasoactive
substances, which are formed in response to changes in the metabolic needs of the body’s
organs and tissues (Haddy & Scott, 1968). Their primary mechanism of action is
modulating the diameter of smooth muscle, through vasoconstriction and vasodilation,
modifying TPR and effectively altering arterial BP. The most common of these
substances include potassium (K+), adenine derivatives, and endothelium-derived
substances such as nitric oxide (NȮ) and endothelin-1 (ET-1).
K+ release into the interstitial space around arterioles is a byproduct of muscular
depolarization, and thus increased muscular activity can lead to an accumulation of
interstitial K+ (Haddy et al., 2006). An increase in the concentration of K+ stimulates the
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sodium-potassium (Na+/K+) pump within the membrane of the smooth muscle (Haddy et
al., 2006). As the Na+/K+ pump is electrogenic its increased stimulation results in
hyperpolarization of the smooth muscle cells (Anderson, 1976; Haddy et al., 2006).
Hyperpolarization of these cells increases the both the stimulus strength and time
required for depolarization, effectively reducing the rate and magnitude of Ca2+ influx.
The influx of extracellular Ca2+ is the main mechanism responsible for smooth muscle
vasoconstriction (Karaki et al., 1997). As such, decreased Ca2+ influx reduces smooth
muscle vasoconstriction allowing for increased tissue blood flow, reduced TPR, and
decreased arterial BP. Increased tissue blood flow provides added blood supply to meet
the increased metabolic demands of the working muscle tissue.
Derivatives of adenine, including adenosine triphosphate (ATP) and the
byproducts of its catabolism, adenosine diphosphate (ADP), adenosine monophosphate
(AMP), and adenosine itself (depending on the location of action) are considered
vasodilatory substances (Haddy & Scott, 1968). ATP is a key substrate involved in
muscular contraction. As such, a decrease in the concentration of ATP, and an increase
in the concentration of the byproducts of its catabolism, is an indication of increased
muscle metabolism. An increase in these metabolites induces a vasodilatory response in
the vascular beds supplying the working tissues to meet the increased metabolic demand
(Haddy & Scott, 1968).
The most potent vasoactive substance, NȮ, also evokes a vasodilatory smooth
muscle response (Steinburg et al., 1994). The increased metabolic demands of working
muscle during exercise are met through increased blood flow to these tissues. Elevations
in the rate and magnitude of blood flow increase shear stress, the force of the flowing
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blood against the blood vessel walls, on the vascular endothelium lining the blood vessels
supplying the muscles. Shear stress of the vascular walls is a potent stimulator of NȮ
production (Corson et al., 1996). Likewise, chemical stimuli (e.g. ACh and bradykinin)
are also stimulators of endothelial NȮ production (Fleming & Busse, 2003). NȮ is
synthesized from the amino acid L-arginine via the NȮ synthase enzyme (eNOS) and
diffuses out of the vascular endothelium (Moncada & Higgs, 1993). Once diffused, NȮ
interacts with the vascular smooth muscle cells activating guanylyl cyclase and causing
an accumulation of cyclic guanine 3,5 monophosphate (cGMP) (Umans & Levi, 1995).
Accumulation of cGMP triggers the activation of cGMP-dependent protein kinase, which
increases myosin light chain (MLC) phosphatase activity (Umans & Levi, 1995; Webb,
2003). Increased MLC phosphatase activity inhibits smooth muscle contraction via
inhibition of the binding of actin and myosin (Umans & Levi, 1995; Webb, 2003). As
such, the response is smooth muscle vasodilation, increased blood flow, and decreased
TPR and arterial BP.
Vasodilatory substances such as K+, adenosine derivatives, and NȮ are counterbalanced by locally released vasoconstrictive substances. ET-1 is released by the
endothelium in response to chemical (angiotensin II, catecholamine, cytokine, hypoxic,
growth factor) or mechanical (shear stress) stimulation (Touyz & Shiffrin, 2003). ET-1
induces vasoconstriction when bound to the ETa receptor through the initiation of a
signaling cascade leading to the release of sequestered Ca2+ and the opening of Ca2+
membrane channels (Pollock et al., 1995). As intracellular Ca2+ determines the
contractile state of smooth muscle, an increase in intracellular Ca2+ can induce
vasoconstriction though increased smooth muscle contraction (Karaki et al., 1997).
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Increased vasoconstriction increases TPR and, therefore, arterial BP. ET-1 can also
regulate the contractile state of the smooth muscle via a negative feedback loop. When
ET-1 binds to ETb receptors it stimulates the release of NȮ, the potent vasodilator
described above (Pollock et al., 1995).
1.1.3 Measurement of Blood Pressure
The desire to measure the pressure of blood in the human body has led to the
evolution of a number of measurement techniques. On the grandest scale these
techniques can be divided into invasive or non-invasive measures. As one might surmise,
invasive measures of arterial BP involve the insertion of a catheter into the artery to allow
for direct, continuous recording of arterial BP (Perloff et al., 1993). Although this is
considered the gold standard of arterial BP measurement the nature of this technique
makes it impractical for use in clinical settings (Perloff et al., 1993). A number of noninvasive techniques, such as auscultatory sphygmomanometry, automated oscillometry,
ultrasonography, the finger cuff method of Penaz, and applanation tonometry have been
developed for non-invasive arterial BP measurement.
Sphygmomanometry and Auscultation
Measurement of arterial BP using sphygmomanometry and auscultation is
considered the gold standard of non-invasive arterial BP measurement in clinical practice.
This method involves placement of an inflatable cuff around the arm, above the elbow, to
be used for brachial artery occlusion. This cuff is manually inflated to a pressure above
SBP to fully occlude the artery in preparation for auscultation (Beevers et al., 2001).
During brachial artery auscultation the pressure of the cuff is manually released at a
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gradual rate of approximately 2-3 mmHg per second (Beevers et al., 2001). As the
pressure of the cuff is released the observer will note a number of Korotkoff sounds. The
first Korotkoff sound occurs when the pressure in the cuff drops below systolic arterial
pressure and blood begins to flow through the artery (Korotkoff, 1905). The cuff
pressure at this first Korotkoff sound is representative of SBP (Korotkoff, 1905). As the
pressure of the cuff is continually decreased the observer will hear a series of 4 more
Korotkoff sounds with the last one followed by a state of silence, which signifies DBP
has been passed (Korotkoff, 1905).
Though this method of arterial BP measurement is considered the non-invasive
gold standard there are notable limitations and disadvantages. The link between the
pressure measurement of the cuff and the instance of the various Korotkoff sounds is the
observer taking the measurement. As such, measurements may be influenced by terminal
digit preference, observer prejudice, and/or observer bias (Beevers et al., 2001).
Additionally, the Korotkoff method has been noted to give SBP and DBP values that are
lower than direct intra-arterial measures (Holland & Humerfelt, 1964). These variances
have been reported to be as great as 25 mmHg in certain cases (Breit & O’Rourke, 1974).
Lastly, the auscultatory gap, which is a disappearance of the Korotkoff sounds between
SBP and DBP only to return as deflation continues, may affect measures using this
method (Pickering et al., 2005). This phenomenon tends to occur in older individuals
with wide pulse pressures, but can often be eliminated by elevating the arm overhead for
30 seconds and returning it to its normal position for measurement (Pickering et al.,
2005). This technique reduces vascular volume within the arm to allow for a greater
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inflow of blood and improved Korotkoff sounds during measurement (Pickering et al.,
2005).
Automatic Oscillometry
The automated oscillometric technique, developed by Etienne-Jules Marey in
1876, measures oscillations in pressure within a sphygmomanometer cuff during gradual
deflation (Langewouters et al., 1998). The amplitude of these oscillations first increases
and then decreases during gradual deflation and the peak amplitude corresponds with
mean arterial pressure (Mauck et al., 1980; Langewouters et al., 1998). As these
oscillations begin well above SBP, and continue below DBP, these values can only be
indirectly estimated via an empirically derived algorithm (Pickering et al., 2005;
Langewouters et al., 1998). This method is advantageous because placement of a
transducer is not required, allowing for greater variability in cuff placement, and it is less
susceptible to external noise (Pickering et al., 2005). The most prominent disadvantage
of this method is that the oscillations may be influenced by factors other than arterial BP,
such as arterial stiffness (Pickering et al., 2005). Further, the algorithm used to derive
SBP and DBP is determined by the manufacturer and programmed into the device
(Pickering et al., 2005).
Ultrasonography
Measurement of arterial BP using ultrasonography requires a sphygmomanometer
cuff, used to occlude arterial blood flow, and an ultrasound transmitter and receiver, used
to detect arterial wall movement. The cuff is initially inflated above SBP to occlude
arterial blood flow while the ultrasound device is placed over the occluded artery. As the
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cuff is steadily deflated there is a noticeable movement of the arterial wall once the
pressure of the cuff meets SBP which causes a Doppler phase shift in the reflected
ultrasound (Pickering et al., 2005). Just as the onset of arterial wall movement signifies
SBP the point at which this movement begins to diminish signifies DBP (Pickering et al.,
2005). Determination of arterial BP using ultrasonography is particularly useful for
individuals with faint Korotkoff sounds and in infants and children (Pickering et al.,
2005; Elseed et al., 1973).
Penaz/Wesseling Method
This method, developed by Penaz and Wesseling, involves the placement of a
small pressure cuff around the finger. Arterial size is determined, and pulsation within
the finger is detected, by an infrared transmission plethysmograph located under the cuff
(Langewouters et al., 1998). The changes in arterial diameter detected by the
plethysmograph feeds a servo-loop, which modulates cuff pressure to hold the artery in a
constant-diameter partially opened state (Pickering et al., 2005). The arterial size setpoint value of the servo-system was provided by the Physiocal criteria of Wesseling
(Wesseling et al., 1995). Oscillations in arterial pressure are measured via an electric
gauge and recorded as an indirect measure of the intra-atrial pressure waveform
(Langewouters et al., 1998; Pickering et al., 2005). Further analysis by a pattern
recognition program provides both systolic and diastolic pressure data per heart beat
(Langewouters et al., 1998). This method has been shown to result in measures that are
lower than direct intra-arterial measures and this has been attributed to differences in the
pressure gradients of the hand versus the brachial artery (Imholz et al., 1991).
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Tonometry
Measurement of arterial BP using tonometry is based upon a principle that states
when an artery is partially compressed or splinted against a bone, the resulting pulsations
are proportional to the intra-arterial pressure changes (Pickering et al., 2005). This
technique continuously measures changes in arterial pressure through the cardiac cycle to
determine the pulse pressure waveform. During resting conditions the average SBP and
DBP measurements determined using tonometry correspond well with intra-arterial
measures (Sato et al., 1993). This method is not without its limitations, most notably the
position sensitivity of the probe over the artery. As proper signal transduction requires
the probe to be situated directly over the center of the artery this technique is very
position dependent (Pickering et al., 2005). Further, excessive hold-down forces may
skew pressure waveforms, motion artifacts may infiltrate the data output, and the
calibration of the tonometer requires the use of an external arterial BP measurement
device (Wang et al., 2004).
1.1.4 Pathophysiology of Hypertension
HT is a prominent risk factor for CVD, which is currently a leading cause of
morbidity and mortality in Canadians of both sexes (Statistics Canada, 2009). HT in
adults is defined as having a resting SBP above 139 mmHg, and/or a resting DBP above
89 mmHg (Chobanian et al., 2003), and afflicts over 4.6 million Canadians (Statistics
Canada, 2009). This is in contrast to normal resting arterial BP, which as stated
previously in 1.1.2 Arterial Blood Pressure Regulation is identified as <120/80 mmHg
(Chobanian et al., 2003). HT can be further subdivided into stages defined by ranges of
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resting arterial BP. Stage 1 HT is defined as a resting arterial BP within the range of 140159/90-99 mmHg, whereas stage 2 HT encompasses resting arterial BP above 160/100
mmHg (Chobanian et al., 2003). Genetic and environmental factors, along with
alterations in sex hormones with increasing age, have been implicated in the development
of HT (Coylewright, 2008). Although significant improvements in screening, prevention,
and treatment have been made, HT remains a major health problem for Canadians.
Types of Hypertension and their Characteristics
At the most general level HT can to divided into 2 categories: primary or
secondary HT. Primary HT is the most common and denotes HT of an unknown cause
(Carretero & Oparil, 2000), whereas secondary HT is far less common and signifies HT
due to a known pathophysiology (Chobanian et al., 2003). Other HT sub-types include
isolated systolic, resistant, malignant, and white-coat HT.
Primary Hypertension
Primary (essential, idiopathic) HT is characterized by elevations in resting arterial
BP due to an unknown cause (Messerli et al., 2007; Carretero & Oparil, 2000). This type
of HT is the most common, constituting approximately 95% of all cases (Carretero &
Oparil, 2000), and numerous lifestyle factors may accumulate to initiate this sustained
rise in BP. These factors, termed hypertensinogenic, are defined as substances or
situations that tends to increase resting arterial BP and include aging, obesity, insulin
resistance, excessive sodium intake, excessive alcohol intake, a sedentary lifestyle,
excessive stress, low potassium intake, and/or low calcium intake (Sever & Poulter,
1989; INTERSALT, 1988). Further, these factors may interact with individually
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inherited genetic traits resulting in modifications of resting arterial BP, which may lead to
the onset of primary HT (Carretero & Oparil, 2000).
Secondary Hypertension
Secondary HT is defined as an elevated resting arterial BP due to a recognized
underlying pathophysiology of the renal system, endocrine system, vascular system,
lungs, and/or central nervous system (Chobanian et al., 2003). As the underlying
pathophysiology causing secondary HT is identifiable, this condition is often referred to
as curable or reversible (Danielson & Dammstrom, 1981; Lewin et al., 1985). Although
much less common than primary HT, prevalence estimates of secondary HT range from
approximately 5 to 10% (Berglund et al., 1976; Omura et al., 2004). Notable causes of
secondary HT involve endocrine disorders (Sica, 2008; Chiong et al., 2008), renovascular
disorders (Ram et al., 1995; Chiong et al., 2008), adrenal disorders (Chiong et al., 2008),
neurological disorders (Chiong et al., 2008), pharmacological side effects (Chiong et al.,
2008), and/or aortic diseases (Bhat et al, 2001; Chiong et al., 2008). One must also
consider the possible co-existence of multiple factors, as well as interactions between
factors, when identifying the underlying pathophysiology of individuals with secondary
HT.
Hypertension Sub-Types
Isolated Systolic Hypertension
Isolated systolic HT has been generally defined as having a SBP of ≥140 mmHg,
with a DBP of ≤ 90 mmHg. Early literature suggests that this type of HT predominantly
affects the elderly, but more recent evidence indicates that isolated systolic HT is also the
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predominant form of HT in adolescents and young adults (Franklin et al., 2001; Chiolero
et al., 2007). This is consistent with the statement that isolated systolic HT is the most
prevalent form of primary HT when considering all cases (Izzo et al., 2000).
There is clear evidence to support the notion that controlling isolated systolic HT
leads to reductions in mortality, incidence of cardiovascular events, and stroke (Garland
et al., 1983; Curb et al., 1985). Further, SBP has been shown to be more important than
DBP in predicting cardiovascular morbidity and mortality (Rhutan et al., 1989; Kannel,
1974). The pathophysiology of isolated systolic HT can be divided into both structural
and functional changes. Structurally, isolated systolic HT may be caused by a decrease in
arterial compliance through stiffening of the arteries leading to increased peripheral
resistance and elevated resting arterial BP (Kannel et al., 1971; Beltran et al., 2001).
Isolated systolic HT is also associated with increases in SNS activity (Grassi et al., 1999),
which may lead to structural remodeling, further increasing peripheral resistance and/or
altering vascular distensibility (Heagerty, 1997).
Resistant Hypertension
Resistant HT is characterized by a persistent elevation in resting arterial BP, with
failure to reach goal targets (e.g., arterial BP controlled to within the normal range),
despite the concurrent use of at least 3 anti-hypertensive agents (See: 1.1.5 Treatment
and Prevention of Elevated Blood Pressure below for details regarding
pharmacological treatment of HT) of different classes (Chobanian et al., 2003; Calhoun et
al., 2008). Further, persons with controlled resting arterial BP via 4 or more antihypertensive agents are also considered resistant to treatment (Calhoun et al., 2008). Due
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to factors such as poor adherence and under-treatment it is difficult to ascertain the
precise prevalence of resistant HT independent of uncontrolled HT. Nonetheless, large,
diverse, well-designed control trials provide evidence that this type of HT is fairly
common (Cushman et al., 2002).
The pathophysiology of resistant HT is multifaceted and may involve
contributions from various sources. More specifically, lifestyle factors such as obesity,
alcohol intake, and sodium consumption along with secondary causes including
obstructive sleep apnea, pheochromocytoma, primary aldosteronism, Cushing’s
syndrome, renal artery stenosis, renal parenchymal disease, hyperparathyroidism, aortic
coarctation, and intracranial tumors have been implicated in the pathophysiology of
resistant HT (Calhoun et al., 2008). A common thread between these factors is an
increase in SNS activity, possibly due to excess aldosterone levels (Wray & Supiano,
2010; Gaddam et al., 2008), which has been proposed as a primary underlying
mechanism of resistant HT (Calhoun et al., 2008; Tsioufis et al., 2011).
Malignant Hypertension
Malignant HT is defined by a sudden, large rise in arterial BP combined with a
malignant vascular injury (Fleming, 2000). Pathological changes underlying malignant
HT include endothelial injury, arteriolar modifications, and glomerular ischemia
(Ruggenenti & Remuzzi, 1996). More specifically, kidneys often show cortical and subcapsular hemorrhaging, while arteries may show proliferative endarteritis, necrosis, and
nucleoid changes, and interlobular arteries may narrow due to fibrin, intimal hyperplasia,
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and collagen deposits (Ruggenenti & Remuzzi, 1996). Taken together these factors may
decrease renal tissue perfusion and lead to local ischemia.
Presentation of this disorder can occur independently, but it often complicates
concomitant primary or secondary HT (Kitiyakara & Guzman, 1998). Although
uncommon, this type of HT affects approximately 1% of those individuals already
experiencing HT and is more prevalent in younger adults (Kitiyakara & Guzman, 1998).
Further, the incidence of malignant HT is twice as high in males as compared to females
(Kitiyakara & Guzman, 1998). Early investigations of malignant hypertension indicated
poor prognosis and low patient survival rates, often due to uraemia (Kincaid-Smith et al.,
1958; Leishman, 1959), but advancements in pharmacological treatments have
significantly improved patient outcomes (Gudbrandsson et al., 1979; Gonzalez et al.,
2010).
White Coat Hypertension
White coat HT is a unique transient situation in which individuals experience
increased resting arterial BP readings in a clinical setting while maintaining arterial BP
levels within normal ranges during regular daily living (Verdecchia et al., 2001). This
white coat effect can be determined by comparing the average resting arterial BP
measurements taken in a clinical setting to average daytime ambulatory BP readings.
There is still much debate in the literature regarding potential cardiovascular risks
associated with white coat HT. Long-term follow up studies suggest an increased
incidence of cardiovascular events and/or disease progression in individuals with white
coat HT relative to their normotensive peers (Gustavsen et al., 2003; Mancia et al., 2009),
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while other investigations dismiss any significant risks associated with white coat HT
(Grosse et al., 1993; Cohen & Townsend, 2010). Nonetheless, it appears that individuals
who exhibit white coat HT may be more disposed to developing sustained HT with age
(Mancia et al., 2009).
1.1.5 Treatment and Prevention of Elevated Blood Pressure
The primary goal of reducing resting arterial BP is to decrease morbidity and
mortality related to cardiovascular and renal disease (Chobanian et al., 2003). Primary
prevention and treatment recommendations for HT can be divided into two general areas:
lifestyle modifications and pharmacological therapies. As most individuals with HT
experience reductions of DBP concomitant to reductions in SBP the primary focus of
these therapies is reaching target SBP levels (Chobanian et al., 2003). The treatment goal
for individuals with HT, but without co-morbidities such as heart failure, diabetes, or
chronic kidney disease, is to lower resting arterial BP below 140/90 mmHg (Chobanian et
al., 2003). Further, for individuals with prehypertension (BP 120-129/80-89 mmHg), and
no other co-morbidities, it is recommended that resting arterial BP should be reduced to
within the normal range (<120/80 mmHg) through lifestyle modifications (described
below) to prevent a progressive rise in resting arterial BP (Chobanian et al., 2003).
Lifestyle Modifications
As mentioned above, lifestyle modifications (dietary and physical activity) are
cornerstones of prevention and treatment programs for those with, or at risk for, HT.
Changes in the composition of an individual’s diet and/or physical activity patterns are
the first and most common suggestions for HT management (Chobanian et al., 2003;
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Pescatello et al., 2004). Modifications that focus on HT management through
consumption of healthier foods and regular physical activity have been shown to be
effective in lower the resting arterial BP of multiple populations (Appel et al., 1997;
Roberts et al., 2002; Blumenthal et al., 2010). The hypotensive effects of improved
dietary food composition can be augmented through decreased alcohol intake, limited
sodium consumption, and the maintenance of a healthy body weight (Chobanian et al.,
2003). Further, adhering to the guidelines put forth in the Dietary Approaches to Stop
Hypertension (DASH), which combines dietary modifications and physical activity, may
provide added hypotensive benefits (Appel et al., 1997; Chobanian et al., 2003).
The DASH guidelines emphasize the consumption of fruits, vegetables, and lowfat dairy products while also including whole grains, fish, poultry, and nuts while limiting
consumption of red meat, sweets and sugary beverages, total fat, saturated fat, and
cholesterol (Appel et al., 1997). Though all individuals do not respond to the DASH diet
to the same degree, responses are often equivalent to those observed through
pharmacological treatment (Chobanian et al., 2003). The DASH diet itself has been
shown to significantly reduce SBP, but there is support for additive effects of restricted
sodium consumption, which may provide a more potent hypotensive response (Vollmer
et al., 2001; Sacks et al., 2001). Though DASH non-responders may not experience the
desired decreases in resting arterial BP, they may experience indirect health benefits,
such as improved body composition, by adhering to healthier dietary food intakes.
As mentioned above, increased physical activity is an important component of the
lifestyle modifications recommended for the prevention and treatment HT. The specific
effects of chronic exercise training, as well as those of acute exercise, on resting arterial
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BP, are discussed in detail below in the section entitled: Exercise and Arterial Blood
Pressure.
Pharmacological Treatment
When lifestyle modifications and exercise interventions fail to elicit the desired
decreases in resting arterial BP pharmacological treatment is recommended. There are
different classes of pharmacologic substances that can be used alone or in combination to
treat elevated resting arterial BP. The most common classes of pharmacological
substances used to treat elevated BP include: diuretics, which increase water excretion
from the body through their actions on the renal tubule, ACE inhibitors, which block the
conversion of angiotensin I to angiotensin II, angiotensin receptor blockers, which block
the activation of angiotensin II receptors, β-blockers, which block the binding of
catecholamines to beta receptors in the heart and smooth muscle, and calcium channel
blockers, which inhibit the movement of Ca2+ across the membrane of the smooth
muscle. The site of action of each of these substances may differ, but the desired
outcome is the same: decreased resting BP through modulation of Q or TPR in an effort
to decrease the morbidity and mortality associated with HT.
Exercise and Arterial Blood Pressure
Physical activity modification is often used concurrently with dietary changes in
treating and preventing HT. Physical activity can be sub-divided into aerobic-based
exercise modalities, such as walking and cycling, and resistance-based exercise
modalities, such as lifting weights. Further, resistance training can be divided into
dynamic resistance or static (isometric) resistance exercise, as there is growing evidence
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for the efficacy of isometric training in resting arterial BP regulation (McGowan et al.,
2006; McGowan et al., 2007a; McGowan et al., 2007b; Taylor et al., 2003; Millar et al.,
2009; Badrov et al., 2013a; Badrov et al., 2013b). It is important to note that
quantification of exercise includes both an intensity and duration component. Specific
exercise recommendations for hypertensive individuals have been developed by the
American College of Sports Medicine (ACSM) and include 30-to-60 minutes of
moderate (40 to 60% of an individual’s HR reserve) aerobic activity performed 3 to 7
days per week (Thompson, 2010). Though these guidelines focus on aerobic exercise,
resistance training is recommended as an adjunct that can be performed 2 to 3 times per
week (Pescatello et al., 2004).
Chronic Aerobic Exercise
Literature regarding the effects of aerobic based exercise training protocols on
resting BP is plentiful and consistently reports decreases of 5-7 mmHg in resting SBP and
DBP (Halbert et al., 1997; Cade et al., 1984; Kiyonaga et al., 1985). To better understand
the dose-response relationship of aerobic training and BP reduction we can examine the
frequency and intensity of the exercise used in these investigations. A meta-analysis of
aerobic-based interventions on BP modulation reveals a frequency range of 2.5 to 7
exercise sessions per week in the published literature (Cleroux et al., 1999). Though
there may be a positive correlation between exercise frequency and resting arterial BP
reduction it has been noted that approximately 75% of the hypotensive benefits of aerobic
exercise garnered on a 7-session per week protocol can be achieved in 3 sessions per
week (Nelson et al., 1986). With regards to exercise intensity, although multiple metaanalyses suggest exercise intensity does not influence the magnitude of post-training
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resting arterial BP changes, others provide evidence to suggest that moderate, rather than
high, intensity exercise may elicit the greater hypotensive response (Pescatello et al.,
2004; Cleroux et al., 1999). Perhaps the most notable interpretation is that the
hypotensive effects of aerobic exercise do not depend on increases in maximal aerobic
capacity, but the effects do correlate well with an individual’s level of activity with a
higher activity level evoking a more hypotensive response (Cleroux et al., 1999).
The underlying mechanisms driving the hypotensive training response to aerobic
exercise remain unclear. It is currently believed that resting arterial BP alterations due to
aerobic training are more likely a derivative of changes in TPR rather than Q (Pescatello
et al., 2005). Moreover, structural, neural and/or hormonal modifications may also be
underlying mechanisms. Structural changes, including vascular remodeling and
angiogenesis, have been suggested as causal mechanisms for the resting arterial BP
lowering effects of aerobic exercise training (Pescatello et al., 2005). Aerobic exercise
leads to a reduction in pre-capillary vascular resistance (Sexton & Laughlan, 1994),
which may decrease TPR and, therefore, resting arterial BP (Pescatello et al., 2005).
There is also indirect evidence to suggest that chronic aerobic exercise training may
reduce SNS activity (Pescatello et al., 2005), and thus resting arterial BP. Aerobic
training may also modulate resting arterial BP through alterations in vascular
responsiveness. A collection of animal studies has shown that aerobic exercise training
reduces vascular responsiveness to the vasoconstrictors NE and ET-1 (Chen et al., 1994;
Wiegman et al., 1981; Laughlin et al., 2001). Genetic interactions have been estimated to
account for approximately 17% of the reduction in resting arterial BP following aerobic
exercise training although precise mechanisms remain unclear (Rice et al., 2002).
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Acute Aerobic Exercise
During an acute bout of aerobic exercise arterial BP is modulated predominantly
to meet the increased demands of the working muscles. Initially there is an increase in
SBP to reach the necessary tissue perfusion required to maintain the increase in muscular
metabolism (MacDonald, 2002). The observed arterial BP increase occurs due to
increases in both HR and Q via reductions in PNS activation and increases in SNS
activation (MacDonald, 2002). As described previously, the vasculature supplying the
working muscles progressively vasodilates to provide adequate tissue perfusion, which
effectively reduces TPR. After the initial peak in SBP there is a gradual reduction to
normalized levels of approximately 140 – 160 mmHg as the contractile state of the
vasculature, and TPR, becomes stabilized (McArdle et al., 2001).
There are also characteristic arterial BP changes during the periods post-exercise,
most notably being post-exercise hypotension (PEH). Immediately following an aerobic
exercise bout there is a decrease in arterial BP (Kenney & Seals, 1993). This
phenomenon has been observed up to 22h post-exercise and is proportional to preexercise resting arterial BP (Rondon et al., 2002; Kenney & Seals, 1993), such that
individuals with greater pre-exercise resting arterial BP will generally see a larger PEH
response (Kenney & Seals, 1993). The exact mechanisms underlying PEH remain
unclear, though there have been two main hypotheses proposed. The first hypothesis is
that acute aerobic exercise decreases SNS outflow, though how this occurs remains
unclear (Floras et al., 1989; Halliwill et al., 1996). The second hypothesis involves
alterations in vascular responsiveness via decreased transduction of SNS outflow and/or
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increased release of vasodilator substances due to increases blood flow and/or muscular
work (Pescatello et al., 2005).
Chronic Resistance Exercise
Unlike aerobic training, research regarding the benefits of resistance training
programs for resting arterial BP control is much less clear. An early meta-analysis of
studies conducted between 1966 and 1998 indicated an overall decrease of approximately
3 mmHg for both SBP and DBP due to resistance training (Kelly & Kelly, 2000). Similar
results were observed in a meta-analysis spanning 1996 to 2003 with average resting
arterial BP reductions of 3.2 mmHg systolic and 3.5 mmHg diastolic (Cornelissen &
Fagard, 2005), and in its updated version, which expanded the data set to 2012
(Cornelissen & Smart, 2013). Although reductions of this magnitude seem insignificant
it should be noted that decreasing SBP by merely 3 mmHg yields significant reductions
in cardiovascular morbidity and mortality (Verdecchia, 2000). As such, in 1990 the
ACSM recognized resistance training as a beneficial component of a comprehensive
fitness program for healthy adults.
Acute Resistance Exercise
An acute bout of resistance exercise induces a sudden, drastic increase in both
SBP and DBP of up to 400/200 mmHg, respectively (MacDougall et al., 1985). This
response is due to the high intramuscular pressures induced by resistance exercise, which
compresses the vasculature supply blood to the working muscles (Mayo et al., 1999).
This compression increases TPR and may cause blood flow occlusion to the working
muscle (Mayo et al., 1999). In an effort to prevent ischemia and increase muscular
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perfusion the activity of the SNS is increased (HR & cardiac contractility), increasing
arterial BP (MacDougall et al., 1985; Mayo et al., 1999). The arterial BP response to
acute resistance exercise is proportional to the muscle mass activated and muscular work
performed (MacDougall et al., 1985). Unlike aerobic exercise, the occurrence of PEH
with resistance training remains equivocal. If PEH is observed after resistance exercise it
may simply be due to reperfusion of previously working muscles experiencing increased
intramuscular compression (MacDougall et al., 1985; MacDonald, 2002).
Chronic Isometric Hand-Grip Exercise
The role of isometric hand-grip (IHG) exercise in the modulation of resting
arterial BP has received increasing attention over the past decade. Recently endorsed by
the American Heart Association as an alternative BP-lowering treatment, this exercise
modality is a novel form of static-resistance training where individuals perform multiple,
timed, sustained contractions on a programmed handgrip dynamometer at a set
percentage of their maximum voluntary effort (Brook et al., 2013). IHG training has
shown to markedly reduce both resting SBP and DBP in men and women with and
without HT, including those currently on medication(s) to treat their HT, and those who
regularly exercise (McGowan et al., 2006; McGowan et al., 2007a; McGowan et al.,
2007b; Millar et al., 2007, Millar et al., 2008; Peters et al., 2006; Taylor et al., 2003;
Wiley et al., 1992; Ray & Carrasco, 2000; Badrov et al., 2013a; Badrov et al., 2013b).
Collectively, these studies employed IHG training protocols of a wide range of
frequencies (3 to 5 sessions per week), durations (45-second to 2-minute contractions),
intensities (30 to 50% of MVC) and intervention lengths (5- to 10-weeks). Recent metaanalyses concluded that resting arterial BP reductions with IHG training appear similar
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to, if not greater than, those elicited by aerobic exercise training (Kelley & Kelley, 2010;
Cornelissen & Fagard, 2005; Cornelissen & Smart, 2013).
Older females with normal resting arterial BP (<120/80 mmHg) appear to respond
to IHG with greater post-training (8 weeks) resting arterial BP reductions than agematched males (Millar et al., 2008). Further, preliminary results from our research
laboratory (Physical Activity and Cardiovascular Research Laboratory, Department of
Kinesiology, University of Windsor) suggest that in contrast to the older cohort, sex
differences do not exist in response to IHG training in young, healthy normotensive men
and women (Hanik et al., 2012). Unknown is whether older normotensive males and
females respond differently, via neurovascular responses such as HR, BP, smooth muscle
function, and/or HR variability, to the acute exercise stimulus (e.g., an single, acute bout
of IHG exercise). Thus, identifying possible differences in the neurovascular response to
IHG exercise may elucidate the mechanism underlying the observed variation in response
between sexes in older populations.
The underlying mechanisms regulating chronic resting arterial BP responses to
IHG exercise remain equivocal. Furthermore, it is still unclear whether IHG training
elicits a systemic vascular effect, as the untrained limbs are often not analyzed.
McGowan and colleagues (2007b) have shown that IHG training in medicated
hypertensive individuals does not change endothelial-dependent vasodilation in the
untrained limb, but further study is warranted. Nonetheless, current hypothesized
mechanisms of post-IHG training resting arterial BP reductions include improvements in
ANS function, improved NȮ-dependent vascular function (McGowan et al., 2006;
McGowan et al., 2007a; McGowan et al., 2007b; Taylor et al., 2003; Millar et al., 2009;
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Badrov et al., 2013), and/or reductions in oxidative stress (Peters et al., 2006). It is
conceivable that the mechanisms are multi-faceted, and may differ among individual
subjects and populations (e.g., old versus young, medicated versus un-medicated HT).
Acute Isometric Hand-Grip Exercise
The underlying mechanisms regulating the cardiovascular effects of a single,
acute bout of IHG exercise may or may not be similar to that observed during chronic
IHG exercise. Observations immediately after an IHG bout indicate no changes in HR
and an increase in arterial BP due to vascular compression in the working arm, which
increases TPR (Araujo et al., 2011). Further, elevated arterial BP returned to near resting
values after the first minute of post-exercise rest, possibly indicating the progression of
PEH (Araujo et al., 2011). PEH has been observed 1 minute after a single IHG
contraction at 35% MVC in young healthy subjects (Stewart et al., 2007). Likewise, PEH
was also observed 5 minutes post IHG exercise (four 2-minute contractions at 30% MVC
with 1 minute rest intervals) in older individuals (Millar et al., 2009). There is also
indirect evidence of improved cardiac autonomic modulation, possibly due to enhanced
vagal activation, after an acute bout of IHG exercise (Millar et al., 2009). The
mechanisms regulating acute arterial BP responses to IHG exercise may provide insight
into chronic adaptations and/or have clinical implications themselves.
1.2 Reactive Oxygen Species, Oxidative Stress and Arterial Blood Pressure
Reactive oxygen species (ROS), also known as oxidative free radicals, have been
implicated in the pathophysiology of HT and have garnered increasing investigation
(Touyz, 2004; Datla & Griendling, 2010). ROS refer to atoms, molecules or ions that
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have unpaired electrons in their outer valence shells (Chen et al., 2012). This
characteristic makes ROS highly reactive within biological systems, allowing them to
react with adjacent molecules such as proteins, lipids, carbohydrates and nucleic acids
(Chen et al., 2012). ROS are produced through biochemical reactions that reduce the
state of O2 (Hancock et al., 2001). The reduction of O2 produces a number of ROS, the
most common of these including superoxide radicals (Ȯ2), hydrogen peroxide (H2O2),
hydroxyl radicals (OḢ), and peroxynitrite (ONOO-) (Hancock et al., 2001).
Endogenous sources of ROS production include: the mitochondrial electron
transport chain, xanthine oxidase, cyclooxygenase, lipoxygenase, NȮ synthase, heme
oxygenases, peroxidases, hemoproteins such as heme and hematin, and NADPH oxidases
(Pennathur & Heinecke, 2007; Kojda et al., 1999). The most important of these ROS
sources is suggested to be the NADPH oxidase enzyme that, using electrons supplied by
NADPH, catalyzes the reaction of O2 to form Ȯ2 (Hancock et al., 2001). The reduction of
O2 by one electron produces Ȯ2, which is highly reactive due to the unpaired electron in
the outer valence shell (Sies, 1997; Chen et al., 2012). Likewise, O2 can be reduced to
water (H2O), but the intermediate steps include the formation of H2O2 and ȮH (Sies,
1997). These molecules can induce pathophysiological changes to lipids, proteins and
DNA, by altering the structure and function of these cells and tissues (Bandyopadhyay et
al., 1999).
Evidence suggests that ROS are not only negative by-products of substrate
metabolism, but that they may also play a role in cellular signaling (Hancock et al.,
2001). The differing roles of ROS, as signaling molecules or destructive metabolic byproducts, may depend on the concentration of ROS present (Thannickal et al., 2000).
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ROS are continuously produced at relatively low rates during rest, but their synthesis
markedly increases during exercise (Reid & Durham, 2002; Bejma & Ji, 1999). At
relatively low concentrations ROS function as signaling molecules, which maintain
vascular integrity through modulation of smooth muscle contraction and endothelial
function (Touyz et al., 2003). In contrast, chronic elevations in ROS production have
been linked to endothelial dysfunction, lipid peroxidation, smooth muscle cell growth,
inflammation, monocyte invasion, increased contractility and increased extracellular
matrix protein deposition (Diep et al., 2002; Taniyama & Griendling, 2003).
The term “oxidative stress” refers to a state of imbalance between the production
of ROS and the removal and/or stabilization of these substances by cellular antioxidant
defense systems (Rodriguez-Manas et al., 2009). An antioxidant refers to any molecule
capable of neutralizing or stabilizing a free radical before they can damage cells and
tissues (Chen et al., 2012). These substances can be produced endogenously within the
body, or consumed through exogenous dietary sources. The most prominent endogenous
antioxidants include superoxide dismutase (SOD), glutathione peroxidase (GPx) and
catalase (Paravicini & Touyz, 2008). SOD catalyzes the dismutation of Ȯ2 into H2O2
(Chen et al., 2012). H2O2 can then be converted into H2O and O2 via GPx or catalase.
GPx consumes reduced glutathione and convert H2O2 into H2O, while catalase facilitates
the conversion of H2O2 into H2O and O2 (Chen et al., 2012; Paravicini & Touyz, 2008).
The balance between oxidants and antioxidants may be key in the pathophysiology of
many chronic diseases, and accordingly, oxidative stress has been implicated in HT as
well as atherosclerosis, vascular disease, diabetes, and aging (Harman, 1956; Pannathur
& Heinecke, 2007; Touyz, 2004; Higashi et al., 2002).
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Effects of Exercise on Reactive Oxygen Species and Blood Pressure Regulation
As alluded to above, oxidative stress is thought to play an important role in
arterial BP regulation and the underlying pathophysiology of HT (Nakazono et al., 1991;
Ferroni et al., 2006; Harrison et al., 2007), and its reduction has been implicated in the
resting arterial BP reductions observed with IHG training (Peters et al., 2006).
When the endogenous antioxidant capacity becomes saturated continued
production of ROS induces a state of oxidative stress. ROS produced in the neural, renal,
and vascular systems are implicated in the pathophysiological signaling that leads to the
development of HT (Datla & Griendling, 2010). Further, increased bioavailability of
ROS can promote endothelial dysfunction through reductions in NȮ bioavailability
(Pennathur & Heinecke, 2007), upregulation of the RAAS (Diep et al., 2002), increases
in systemic inflammation (Diep et al., 2002), and vascular remodeling (Shiffrin, 2004).
These outcomes can individually and collectively contribute to the sustained elevations in
resting arterial BP associated with HT.
The relative importance of NȮ to the health and function of endothelium, and its
reduced bioavailability due to ROS, has prompted increasing investigation into the
implications for HT development. The ROS Ȯ2 is able to react with NȮ to produce the
highly reactive ONOO- (Hancock et al., 2001). As the rate of reaction between Ȯ2 and
NȮ is far greater than the rate of reaction between Ȯ2 and SOD, an endogenous
antioxidant capable of neutralizing its activity, Ȯ2 will more readily react with NȮ (Chen
et al., 2012). As NȮ serves an important role in the health and contractile state of the
smooth muscle (Sarkar et al., 1996; Moncada et al., 1991), a decrease in its
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bioavailability may produce negative consequences to vascular health, impaired
vasodilation, and increased resting arterial BP.
ROS may further influence the bioavailability of NȮ through its actions on the
critical eNOS cofactor tetrahydrobiopterin (BH4). When reactive Ȯ2 is produced from
vascular NAD(P)H oxidase enzymes it oxidizes BH4 and reduces the bioavailability of
this critical cofactor (Landmesser et al., 2003). In the presence of reduced amounts of
BH4, and increased amounts of oxidized BH4, the stimulation of eNOS produces large
amounts of Ȯ2 (Bevers et al., 2006; Landmesser et al., 2003). The negative consequences
of this cycle, namely chronic reductions in NȮ and increases in Ȯ2, may be critical in the
progression and underlying pathophysiology of HT.
Reactive Oxygen Species Production and Acute Exercise
In general, acute exercise leads to increased O2 consumption and an increase in
the production of ROS, such as Ȯ2, from oxidative metabolism (Bejma & Ji, 1999). With
respect to aerobic exercise, transient increases in ROS production and consequent
oxidative stress, as indicated by an increased ratio of oxidized glutathione-to-total wholeblood glutathione ratio (GSSG:TGSH), have been observed following an acute bout of
aerobic exercise (Bloomer et al., 2005). Participants cycled at 70% of VO2max for 30
minutes and blood was drawn for analysis pre, post, 1h-post, 6h-post, and 24h-post
exercise. The GSSG:TGSH ratio was increased immediately following exercise, but
returned to baseline at 1h-post exercise. The authors hypothesized that an acute increase
in oxidative modification of TGSH occurs immediately post-exercise, increasing
production of GSSG, but the rapid action of glutathione reductase catalyzes the
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conversion of GSSG to reduced glutathione (Bloomer et al., 2005). It is possible that the
observed oxidative stress in this study is due to increased Ȯ2 bioavailability. To
neutralize reactive Ȯ2 it can be converted to H2O2 by the enzyme SOD (Gohil et al.,
1988). H2O2 formed by this reaction is then neutralized by the actions of the enzyme
glutathione peroxidase, which converts H2O2 to H2O, but in the process produces GSSG
(Gohil et al., 1988). The observation of increased oxidative stress after acute aerobic
exercise of differing intensities (i.e.: exhaustive, prolonged) and modalities (i.e.: running,
cycling) has been repeatedly shown in the literature (Alessio et al., 2000; Sastre et al.,
1992; Gohil et al., 1988).
Acute resistant exercise also augments ROS production, possibly leading to
oxidative stress and the associated negative consequences. A circuit of resistance
exercise (10 exercises, 9 repetitions, at 75% of 1 repetition maximum (RM)) acutely
increased plasma antioxidant concentrations (α-tocopherol, γ-tocopherol, β-carotene,
lycopene), but this was not sufficient to prevent augmented lipid peroxidation
immediately post-exercise (Ramel et al., 2004). Likewise, a resistance training circuit (2
circuits, 8 exercises, 3 sets of 10 repetitions at 100% of 10 RM) significantly increased
the concentration of malonyldialdehyde (MDA) immediately post-exercise. MDA is a
biomarker of free radical interaction with the lipids of cell membranes. The observation
that acute resistance exercise elicits significant increases in the concentration of MDA
has been shown repeatedly (Hoffman et al., 2007; Heunks et al., 1999). There is also
evidence of significant increases in xanthine oxidases, which can generate Ȯ2,
immediately post-resistance exercise (Heunks et al., 1999). As resistance exercise does
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not tax aerobic metabolism heavily future study should attempt to elucidate possible
differences between acute aerobic and resistance ROS production.
This observation is not unique to aerobic or resistance exercise modalities and has
also been observed following an acute bout of IHG. For example, in work conducted by
Alessio et al. (2000), participants performed 45 second contractions at 50% MVC with 45
second rest periods until the accumulated time was equal to the time it took to complete a
VO2max test (approximately 15 minutes) (Alessio et al., 2000). Increases in lipid
hydroperoxides, an indicator of increased oxidative stress, were observed immediately
post-exercise (Alessio et al., 2000). These findings may be due to increased post-exercise
bioavailability of Ȯ2 generated via: metabolite-induced production, exercise-induced
temperature rise, mechanical-stress induced inflammation and/or ischemia-reperfusion
(IR) induced production (Alessio et al., 2000; Holecek et al., 2004). Ȯ2, if not
neutralized, can be reduced or dismutated to H2O2, which can be further reduced by iron
to produce ȮH, a free radical capable of peroxidation and lipid hydroperoxide production
(Girotti, 1998).
Work by McGowan et al. (2006) supports the observation of increased oxidative
stress following an acute IHG bout. Investigators observed post-IHG bout reductions in
NȮ-dependent vasodilation in the brachial artery of the exercised limb (an indirect
indication of increased oxidative stress) immediately following a bout of IHG (4x2minute unilateral contractions at 30% MVC with 4-minutes rest between) in an older
population of medicated hypertensives, which is suggestive of reduced local NȮ
bioavailability. As Ȯ2 reacts rapidly with NȮ it is plausible that acute IHG exercise
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augments Ȯ2 production, reducing NȮ bioavailability, inhibiting NȮ-dependent
vasodilation.
ROS Production and Chronic Exercise
Most importantly, while a single bout of aerobic or IHG exercise acutely
increases ROS production and oxidative stress, this effect is transient, and chronic
exposure to either stimulus leads to adaptation and an increased basal antioxidant
capacity (Peters et al., 2006; Miyazaki et al., 2001).
Although the acute effects of augmented ROS production due to aerobic exercise
may be interpreted as detrimental to health, they appear to serve a beneficial long-term
purpose. For example, chronic aerobic exercise training (i.e., repetitive exposure to acute
bouts) leads to lower levels of oxidative damage after an intense exercise bout due to
upregulation of antioxidant enzymes such as SOD, GPx, and glutamylcysteine synthase
(Salminen & Vihko, 1983). Likewise, increased SOD activity in response to aerobic
training has been shown repeatedly in animal studies of various durations, intensities, and
lengths (Higuchi et al., 1985; Powers et al., 1994; Leeuwenburgh et al., 1997). If chronic
aerobic exercise increases the endogenous antioxidant capacity of the system it could
neutralize greater concentrations of ROS, such as Ȯ2, preventing the negative effects of
oxidative stress (i.e.: reduced NȮ bioavailability) from negatively effecting arterial BP.
As with aerobic training, ROS produced during acute IHG bouts may also confer
long-term benefits. It has been shown that, following 6 weeks of IHG training (3
sessions per week, four total 45s contractions at 50% MVC, bilaterally, with 1 minute
recovery between intervals), there is a marked increase in the resting TGSH:GSSG, an
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indication of increased antioxidant capacity (Peters et al., 2006). This work was
supported by McGowan and colleagues who observed, in the group of participants with
hypertension described above, an improvement in NȮ-dependent function of the brachial
artery at rest (McGowan et al., 2006; McGowan et al., 2007a; McGowan et al., 2007b),
which is suggestive of an increased basal antioxidant capacity. Further, there is evidence
to suggest that IHG training results in improved basal NȮ-dependent resistance vessel
function (McGowan et al., 2007a; Badrov et al., 2013). Increased antioxidant capacity
through repeated exposures to the IHG stimulus may provide a greater capacity to
neutralize future increases in free radical production, reduce the incidence and severity of
oxidative stress, improve basal NȮ-dependent dilation supporting improved resistance
vessel function, leading to resting arterial BP reduction. It is important to note, however,
that post-bout attenuation in vascular function (FMD) was unchanged with 8-weeks of
IHG training, suggesting that although basal function is improved with chronic exposure
to the IHG stimulus, there is a lack of adaptation in stress-induced ROS antioxidant
buffering capacity (McGowan et al., 2007a).
The observed improvements in NȮ-dependent vasodilation may be due to
increased basal antioxidant concentrations. As stated previously, Ȯ2 reacts rapidly with
NȮ reducing its bioavailability and inhibiting NȮ-dependent vasodilation. Increased
basal antioxidant action would better ameliorate the effects of elevated ROS production
preserving NȮ for its role in resistance vessel function and arterial BP regulation. The
IHG studies to date have been underpowered to detect sex-based differences in the
vascular responses to acute IHG and/or IHG training, including oxidative stress and
antioxidant capacity, if they do exist.
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1.3 Ischemia-Reperfusion
As mentioned in the above section entitled: Reactive Oxygen Species
Production and Acute Exercise, IR is mechanism of ROS production. IR refers to the
sequence of events whereby the blood supply to cells and tissues is restricted for a period
of time, inhibiting the supply of nutrients required for cellular metabolism, followed by
reintroduction of the blood supply. IR can occur due to trauma, such as during
myocardial infarction or stroke (Dorweiler et al., 2007), but also due to high
intramuscular pressures experienced during some exercise modalities, such as IHG
exercise at 30% MVC or greater (Sadamoto et al., 1983; Sakakibara & Honda, 1990).
This response is due to the high intramuscular pressures induced by resistance exercise,
which compresses the vasculature supplying blood to the working muscles, increasing
TPR, which may cause occlusion of blood flow (Mayo et al., 1999). Occlusion of blood
flow is known to augment the production of ROS, which can induce a state of oxidative
stress (Kloner et al., 1989). A constant onslaught of oxidative stress would plausibly lead
to a multitude of negative effects, but as the above described chronic exercise training
suggests, there may be a long-term benefit to repeated acute exposures.
Exposure to ischemic conditions can increase antioxidant concentrations, which
may evoke an adaptive response and protection during subsequent exposure to oxidative
stress (Hoshida et al., 1993; Powers et al., 1998). An adaptive response refers to the
ability of an organism to better defend against the damaging effects of a toxic agent after
previous exposure to a lesser dose (Crawford & Davies, 1994). Exposure of various cell
cultures to oxidative stress evokes an adaptive response which renders them much more
resistant to subsequently higher doses (Spitz et al., 1987; Laval, 1988; Lu et al., 1993).
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Further, it has also been shown that aerobic exercise training (running for 1h/day with
increasing speed and gradient over the first 10-weeks to 35m/min at 15% incline, 5
days/week, for 18 weeks), which, as mentioned previously, acutely augments ROS
production, can lead to adaptations that decrease post-exercise lipid peroxidation relative
to sedentary controls (Alessio & Goldfarb, 1988). Lipid peroxidation is a frequently
measured marker of increased ROS production and oxidative stress. Decreased postexercise lipid peroxidation indicates a greater basal antioxidant capacity, capable of
neutralizing augmented ROS production. Lastly, running on a treadmill for 60 minutes
per day at 5m/min at 15% incline, 5 days per week, over a 10-12 week training period has
been shown to restore diminished BH4 in older rats, improving NȮ-dependent
vasodilation within the arterioles (Sindler et al., 2009). Consistent evidence provides
support for the notion that transient exposure to oxidative stress, be it through exercise
and/or IR, may evoke an adaptive response leading to an increased basal antioxidant
capacity.
IHG Exercise and Ischemia Reperfusion
Acute exposure to increased ROS via IR may be the mechanism underlying the
observed positive adaptations due to IHG exercise that improve basal NȮ-dependent
dilation and resistance vessel function while also lowering resting arterial BP. IHG
performed at ≥30% MVC progressively reduces forearm blood flow until total occlusion
occurs at about 70 % MVC (Sakakibara & Honda, 1990). As blood flow to the working
tissues is decreased proportional to force during IHG exercise (Sakakibara & Honda,
1990; Sejersted et al., 1984), and reactive hyperemia is increased during the recovery
phase proportional to exercise intensity (Kagaya & Homma, 1997), it is possible that IR
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is an underlying mechanism of the resting arterial BP reductions observed following 8
weeks of thrice weekly, 30% MVC IHG training. Increased antioxidant capacity may
allow for greater neutralization of Ȯ2 leading to a greater bioavailability of NȮ,
improving resistance vessel function and NȮ-dependent vasodilation. If the resting
arterial BP reductions from IHG exercise could be replicated using a simple IR protocol,
one could quantify the stimulus and isolate IR as a causal mechanism. Furthermore, sexspecific differences in the resting arterial BP response to IR may provide insight into the
observed sex differences in the resting arterial BP response to IHG training in older
populations.
Thesis Purpose & Hypotheses
The purpose of this study was to: 1) quantify the IHG stimulus in terms of the
neurovascular responses and determine if a sex difference exists in these responses, 2)
determine if the IHG protocol has systemic vascular effects and to determine if any
systemic response sex differences exist, and 3) compare the response of the traditional
IHG stimulus to a complementary IR cuff protocol within the exercised limb.
Due to elevations in oxidative stress, it was hypothesized that NȮ-dependent
vasodilation would be transiently reduced in the conduit (brachial) and resistance vessels
of the trained limb immediately following an acute bout of IHG exercise (McGowan et
al., 2006; McGowan et al., 2007a). Further, females were expected to experience a
greater neurovascular response to acute IHG exercise (through greater reductions in NȮdependent vasodilation and reduced resistance vessel function). It was hypothesized that
an acute bout of IHG exercise would produce a systemic vascular response, and that
females would experience a greater response than males. It was also hypothesized that
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the IR cuff protocol would produce similar neurovascular responses to that of an acute
bout of IHG exercise in the exercised limb. As with IHG exercise, it was hypothesized
that females would experience a greater vascular response. With respect to the latter,
sex-specific differences in the arterial BP response to IR may elucidate the observed sex
differences in the resting arterial BP response to IHG training.
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Chapter 2: Sex differences in the neurovascular response to acute isometric
handgrip exercise and a complementary ischemic-reperfusion cuff protocol
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2.1 Introduction
Hypertension (HT), a condition characterized by sustained elevations of resting
systolic (SBP) and/or diastolic blood pressure (DBP), increases the risk of developing
cardiovascular disease (CVD) and afflicts over 4.6 million Canadians (Statistics Canada,
2009). Currently, CVD is a leading cause of morbidity and mortality in Canadians of
both sexes (Statistics Canada, 2009). Genetic and environmental factors, along with
alterations in sex hormones with increasing age, have been implicated in the development
of HT (Coylewright, 2008). Although significant improvements in screening, prevention,
and treatment have been made, HT remains a major health problem for Canadians as
evident by the statistics presented above. Thus, primary prevention strategies targeting
older individuals, a key population at an increased risk for HT development, are very
important.
Isometric handgrip (IHG) training is a novel and simple form of isometric
resistance exercise where participants perform multiple, timed, constant contractions
(squeezes) on a programmed handgrip at a set percentage of their maximal voluntary
contraction (MVC), where each contraction is separated by a timed rest period. This form
of training, recently endorsed by the American Heart Association as a method to reduce
BP (Brook et al., 2013), reduces both resting SBP and DBP in men and women with and
without HT, including those currently on medication(s) to treat their HT, and those who
regularly exercise (McGowan et al., 2006; McGowan et al., 2007a; McGowan et al.,
2007b; Millar et al., 2007, Millar et al., 2008; Peters et al., 2006; Taylor et al., 2003;
Wiley et al., 1992; Ray & Carrasco, 2000; Badrov et al., 2013a; Badrov et al., 2013b).
Collectively, these studies use IHG training protocols of varying frequencies (3 to 5
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sessions per week), durations (45-second to 2-minute contractions), intensities (30 to
50% of MVC) and intervention lengths (5- to 10-weeks). The most commonly employed
and studied bilateral IHG protocol consists of four, two-minute contractions at 30%
MVC, performed with alternating hands with 1-minute rest between. The most common
unilateral IHG protocol consists of four, two-minute contractions at 30% MVC, with 4minutes rest between. Recent meta-analyses have concluded that resting arterial BP
reductions with this form of training appear similar to, if not greater than, those observed
with aerobic exercise training (Kelley & Kelley, 2010; Cornelissen & Fagard, 2005).
Older females with normal resting arterial BP appear to respond to IHG with
greater post-training reductions in resting arterial BP than age-matched males (Millar et
al., 2008). Further, preliminary results from our lab suggest that this is not upheld in a
younger cohort (Hanik et al., 2012), such that both sexes respond to IHG training with
similar magnitudes of resting arterial BP reduction. A small body of evidence exists to
suggest that an acute bout of IHG (four, two-minute contractions at 30% MVC, with 2minutes rest between) elicits an increase in arterial BP due to vascular compression in the
working arm increasing TPR, but no changes in HR (Araujo et al., 2011). Further,
elevated arterial BP returned to near rest after the first minute of post-exercise rest,
possibly indicating the progression to PEH (Araujo et al., 2011). PEH has been observed
1 minute after a single 2-minute IHG contraction at 35% MVC in young healthy subjects
(Stewart et al., 2007). Likewise, PEH was also observed 5 minutes post-IHG bout (four
2-minute contractions at 30% MVC with 1 minute rest intervals) in older individuals
(Millar et al., 2009). The arterial BP changes appear concomitant to improved cardiac
autonomic modulation, possibly due to enhanced vagal activation after an acute bout of
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IHG exercise (Millar et al., 2009). However to date the studies have been underpowered
to detect sex differences, if they do exist. As such, whether older normotensive males and
females respond differently (i.e.: neurovascular responses such as HR, arterial BP,
conduit & resistance vessel function, or HR variability) to an acute bout of IHG exercise,
potentially contributing to the differences in post-training response, remains unknown.
The mechanisms underlying the acute and chronic arterial BP responses to IHG
exercise remain equivocal. Hypothesized mechanisms of post-IHG training resting
arterial BP reductions include improvements in autonomic nervous system function (as
assessed via direct sympathetic outflow to muscle (MSNA), or indirectly via HR
variability), improved NȮ-dependent blood vessel (endothelial) function (McGowan et
al., 2006; McGowan et al., 2007a; McGowan et al., 2007b; Taylor et al., 2003; Millar et
al., 2009; Badrov et al., 2013a), and reductions in oxidative stress (Peters et al., 2006).
The mechanisms underlying the effects of an acute bout of IHG exercise may, or may
not, be similar. It is conceivable that the mechanisms are multi-faceted, and may differ
among individuals (e.g., genetics) and populations (e.g., normotensive versus unmediated
hypertensive versus medicated hypertensive; men versus women). Quantifying the
neurovascular stimulus will provide valuable insight into the mechanisms of IHGinduced arterial BP adaptations.
Exercise (i.e., isometric or aerobic) leads to increased O2 consumption and an
increase in the production of ROS from oxidative metabolism (Bejma & Ji, 1999). With
respect to isometric exercise, increased oxidative stress has been observed following an
acute IHG bout, and has been attributed to increased post-exercise bioavailability of Ȯ2
via: 1) metabolite-induced production, 2) exercise-induced temperature rise and
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mechanical-stress induced inflammation, and/or 3) ischemia-reperfusion (IR) induced
production (Alessio et al., 2000; Holecek et al., 2004). This transient increase in
oxidative stress post-IHG is not unique to an isometric exercise modality, but also occurs
after acute bouts of aerobic exercise (Bloomer et al., 2005). Importantly, while a single
bout of IHG exercise acutely increased ROS production and oxidative stress, this effect is
transient, and chronic exposure to the IHG stimulus leads to adaptation and an increased
basal antioxidant capacity (Peters et al., 2006). As with the work mentioned previously,
samples sizes were too small to detect any sex differences in post-training improvements
in NȮ-dependent function and/or oxidative stress.
The positive adaptation to acute ROS exposure has also been shown in aerobic
exercise studies (Miyazaki et al., 2001). With respect to aerobic exercise, transient
increases in ROS production and consequent oxidative stress, as indicated by an
increased ratio of oxidized glutathione-to-total whole-blood glutathione ratio
(GSSG:TGSH), have been observed following an acute bout of aerobic exercise
(Bloomer et al., 2005). Participants cycled at 70% of VO2max for 30 minutes and blood
was drawn for analysis pre, post, 1h-post, 6h-post, and 24h-post exercise. The
GSSG:TGSH ratio was increased immediately following exercise, but returned to
baseline at 1h-post exercise. The authors hypothesized that an acute increase in oxidative
modification of TGSH occurs immediately post-exercise, increasing production of
GSSG, but the rapid action of glutathione reductase catalyzed the conversion of GSSG to
reduced glutathione (Bloomer et al., 2005). It is possible that the observed oxidative
stress in this study was due to increased Ȯ2 bioavailability. To neutralize reactive Ȯ2 it
can be converted to H2O2 by the enzyme SOD (Gohil et al., 1988). H2O2 formed by this
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reaction is then neutralized by the actions of the enzyme glutathione peroxidase, which
converts H2O2 to H2O, but in the process produces GSSG (Gohil et al., 1988). The
observation of increased oxidative stress after acute aerobic exercise has been repeatedly
shown in the literature (Alessio et al., 2000; Sastre et al., 1992; Gohil et al., 1988).
Although the acute effects of augmented ROS production due to aerobic exercise
appear to be detrimental to health they may serve a very beneficial long-term purpose.
Exposure to chronic aerobic exercise training leads to lower levels of oxidative damage
after an intense exercise bout due to upregulation of antioxidant enzymes such as SOD,
GPx, and glutamylcysteine synthase (Salminen & Vihko, 1983). Likewise, increased
SOD activity in response to aerobic training has been shown repeatedly in animal studies
of various durations, intensities, and lengths (Higuchi et al., 1985; Powers et al., 1994;
Leeuwenburgh et al., 1997). If chronic aerobic exercise augments endogenous
antioxidant production the system could neutralize greater concentrations of ROS, such
as Ȯ2, preventing the negative effects of oxidative stress, such as reduced NȮ
bioavailability, on resting arterial BP regulation.
Work by McGowan et al. (2006) indirectly supports the observation of improved
antioxidant capacity with IHG training. Acutely, investigators observed post-IHG bout
reductions in NȮ-dependent vasodilation in the brachial artery of the exercised limb (an
indirect indicator of increased oxidative stress) in an older population of medicated
hypertensives prior to an 8-week IHG training intervention. Although this acute response
was unchanged with 8-weeks of IHG training, the overall resting NȮ-dependent function
of the brachial artery was improved (McGowan et al., 2006; McGowan et al., 2007a;
McGowan et al., 2007b). Further, there is evidence to suggest that IHG training results in
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improved basal NȮ-dependent resistance vessel function (McGowan et al., 2007a;
Badrov et al., 2013a). Increased antioxidant capacity through a repeated exposure to the
IHG stimulus may provide a greater capacity to neutralize future increases in free radical
production, reduce the incidence and severity of oxidative stress, improve basal NȮdependent dilation supporting improved resistance vessel function, and lead to reductions
in total peripheral resistance and resting arterial BP .
IR with IHG increases ROS production, as mentioned above. It has been shown
that exposure to ischemic conditions can increase antioxidant concentrations, which may
lead to better protection during subsequent exposure to oxidative stress (Hoshida et al.,
1993; Powers et al., 1998). As blood flow to the working tissues is decreased
proportional to force during IHG exercise (Sejersted et al., 1984), and reactive hyperemia
is increased during the recovery phase proportional to exercise intensity (Kagaya &
Homma, 1997), it is possible that IR is an underlying mechanism of resting arterial BP
modulation due to IHG exercise. If the resting arterial BP reductions from IHG exercise
could be replicated using a simple IR cuff protocol (i.e., creating IR via arterial occlusion
using an inflatable cuff), one could quantify the stimulus and isolate IR as a potential
causal mechanism. Further, if there is a sex difference in the vascular response to IR it
may provide insight into the observed sex differences in the resting arterial BP response
to IHG exercise in older individuals (Millar et al., 2008).
Expansion of currently available HT prevention therapies is needed, particularly
in older individuals at risk of developing HT. IHG training is a novel, simple, and timeefficient form of exercise that is effective in reducing resting arterial BP in individuals
with and without high arterial BP, particularly in older women. The inherent sex
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differences in response to the IHG stimulus are under-investigated. Furthermore, the
mechanisms responsible for the observed resting arterial BP reductions and/or existing
sex-differences in these mechanisms, such as basal antioxidant modulation, are not well
known. The rationale for conducting the present study is based upon these experimental
findings. It is hoped that the results of this research will provide further support for the
use of IHG training as a modulator of resting arterial BP, as well as shed light on possible
associated mechanisms and sex differences.
2.2 Purpose & Hypotheses
The purpose of this study was to: 1) quantify the IHG stimulus in terms of the
neurovascular responses and determine if a sex difference exists in these responses, 2)
determine if the IHG protocol has systemic vascular effects and to determine if any
systemic response sex differences exist, and 3) compare the response of the traditional
IHG stimulus to a complementary IR cuff protocol within the exercised limb.
Due to elevations in oxidative stress, it was hypothesized that NȮ-dependent
vasodilation would be transiently reduced in the conduit (brachial) and resistance vessels
of the trained limb immediately following an acute bout of IHG exercise (McGowan et
al., 2006; McGowan et al., 2007a). Further, females were expected to experience a
greater neurovascular response to acute IHG exercise (through greater reductions in NȮdependent vasodilation and reduced resistance vessel function). It was hypothesized that
an acute bout of IHG exercise would produce a systemic vascular response, and that
females would experience a greater response than males. It was also hypothesized that
the IR cuff protocol would produce similar neurovascular responses to that of an acute
bout of IHG exercise in the exercised limb. As with IHG exercise, it was hypothesized
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that females would experience a greater vascular response. With respect to the latter,
sex-specific differences in the arterial BP response to IR may elucidate the observed sex
differences in the resting arterial BP response to IHG training.
2.3 Methods
Study Participants
A total of eight non-smoking, recreationally active (2-3x / week), healthy men
(n=1); 63 years, and women (n=7); 65 ± 4 years, with normal arterial BP (man: 103 ± 13
SBP/68 ± 7 DBP; women: 100 ± 10 SBP/60 ± 5 DBP) were recruited from Essex county
and enrolled in the protocol. Exclusion criteria included any arterial BP or vascular
altering medications, recent hospitalization (<3 months), use of hormone replacement
therapy, diabetes (by history, use of oral hypoglycemic agents or a fasting blood glucose
value >7.0 mmol/L), autonomic neuropathy, frequent premature ventricular heart beats or
a paced heart rhythm at rest, CVD and/or heart failure. The University of Windsor
Research Ethics Board approved the study described herein (REB # 12-207).
Sample size was calculated with consideration of the neurovascular responses
following IHG exercise (Millar et al., 2009; McGowan et al, 2006; McGowan et al,
2007a). With an assigned alpha of 0.05, a beta of 0.2 and an effect size of 0.4, sample
sizes ranging from 6 to 16 were estimated.
Study Design
After inquiring about the study, potential participants who believed they met the
inclusion criteria met with investigators at the Physical Activity and Cardiovascular
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Research lab (PACR; HK 240, Department of Kinesiology, University of Windsor, ON,
Canada) for an informational meeting and, if interested, to sign an informed letter of
consent (Appendix A), a letter of information (Appendix B), followed by the
administration of a medical questionnaire (Appendix C) to determine eligibility. Upon
review of the medical questionnaire and the initial establishment of initial eligibility,
participants had their resting arterial BP measured. Resting arterial BP was measured
following 10-minutes of seated rest using the Dinamap brachial artery oscillometric
device (Appendix D; Dinamap Carescape v100, Critikon, Tampa, Florida, USA).
Specifically, arterial BP measurements involved the placement of a cuff around the right
arm (upper portion), which was inflated to a pressure greater than systolic BP to occlude
the brachial artery. Arterial BP was measured 4 times, with a 2-minute rest period
between measures, and the last 3 values were then averaged (Stiller-Moldovan et al.,
2012; Badrov et al., 2013a; Badrov et al., 2013b).
If resting arterial BP was within the eligible range (< 140/90 mmHg) individuals
who were still interested were given a physical activity readiness medical examination
(PAR-MedX) questionnaire if over the age of 70 years (Appendix E), or a PAR-Q if
under the age of 70 years (Appendix F) and a letter of information for their primary
healthcare provider (Appendix G), both of which were signed by their health care
provider (HCP) and returned to the study investigators prior to the scheduling of the
familiarization session.
Upon completion of all forms, individuals returned to the PACR lab for a
familiarization session. First, participants had their resting arterial BP measured a second
time in the same manner as described above. If average resting arterial BP values from
	
  

70	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

Visit 1 and Visit 2 were < 140/90 mmHg participants were deemed eligible to participate,
and continued with the habituation session and the investigation. Participants then
practiced all portions of the investigation including the IHG exercise protocol. Any
further questions or concerns related to the study were answered at this time. This
session also functioned to reduce participant anxiety as well as reduce possible white coat
effects during subsequent BP readings (Verdecchia et al., 2001). Following the
completion of the familiarization session, testing was then conducted on three separate
days to evaluate neurovascular function (Figure 1; pre- to post-IHG exercise in the
exercised and non-exercised arm, and pre- to post-IR cuff protocol in the cuffed arm).

Figure 1. Vascular testing days
Testing Protocol
Testing days were conducted in random order, and were separated by at least 24
hours. To minimize the influence of external factors on the cardiovascular measurements,
participants were asked to refrain from the consumption of alcohol or the participation in
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vigorous exercise for 24 hours prior to each testing session, to avoid caffeine
consumption for 12 hours prior, and following a 4 hour fast. All testing was conducted in
a quiet, temperature-controlled room at the same time of day according to standardized
published procedures (Stiller-Moldovan et al., 2012). Participants were asked to void
their bladder prior to all testing sessions to minimize the effects of bladder distension on
resting arterial BP (Fagius & Karhuvaara, 1989).
TESTING DAY 1: Assessment of neurovascular function (indirect assessment of
oxidative stress) prior to and following an acute IHG bout in the exercised arm (Time: 2.5
hours)
After 10 minutes of seated rest, arterial BP was be measured 4 times in the right
arm with a 2-minute rest period between measures, and the last 3 values were then
averaged, as described above. Following arterial BP acquisition, participants remained in
a seated position with their non-dominant arm adjusted to an angle of ~90° from their
upper arm, while their arm was rested on a table located directly in front of the
participant. A rapid inflating BP cuff was also placed around the non-dominant forearm
(2-4 cm distal to the antecubital fosse). A 3-lead ECG was attached to record continuous
HR data throughout the protocol (Appendix H; Powerlab ML 870/P, AD Instruments,
Colorado Springs, Colorado, USA).
Neurovascular Measure #1: Brachial artery NȮ-dependent vasodilation was
assessed using a flow-mediated dilation (FMD), a gold standard validated technique, in
accordance with international guidelines (Harris et al., 2010). A linear array vascular
probe (8L-RS; 13MHz), attached to a high-resolution Doppler ultrasound machine
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(Appendix I; Vividi, GE Healthcare, Pittsburgh, PA, USA) was used to image the
brachial artery in the distal third of the upper arm. Ultrasound gel was applied to the area
of interest and ultrasound parameters were set to optimize the clarity of the brachial
artery image. The placement of the probe and anatomical landmarks were recorded for
future imaging sessions to ensure identical placement of the probe during repeat testing.
All recording was performed at an insonation angle of 60 degrees. Recording sample
volume spanned the entire width of the artery, but was clear of the vessel walls. A rapid
inflation/deflation cuff was inflated to 200mmHg and held at a constant pressure for 5
minutes to occlude blood flow, after which time the cuff was released and blood flow
restored to the lower arm. In brief, brachial artery diameters (B Mode) and blood
velocity (PW mode) were recorded continuously for 1 minute prior to cuff inflation and
for 3 minutes following cuff release.
Participants then completed a single bout of IHG, comprising 4, 2-minute
isometric contractions at 30% MVC (determined at the onset of exercise via electronic
linear load cells contained within each IHG device) using the same hand with a 4-minute
rest interval between on a programmed handgrip dynamometer (Appendix J; ZonaPLUS,
Zona HEALTH, Boise, Idaho, USA). Upon completion of this bout, measures of FMD
were repeated.
Participants then underwent 30 minutes of supine rest before measures of
resistance vessel function were taken.
Neurovascular Measure #2: Venous strain-gauge plethysmography (Appendix
K; Hokanson EC6 Strain Gauge and Photo Plethysmograph, D.E. Hokanson, Inc.,
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Bellevue, Washington, USA) with reactive hyperemia was used to assess resistance
vessel function (Badrov et al., 2013a). The non-dominant upper-arm was elevated above
heart level and fitted with an inflatable cuff (Appendix L; Hokanson Cuff, D.E.
Hokanson, Inc., Bellevue, Washington, USA). The largest part of the forearm was then
fitted with a strain gauge (Hokanson EC6 Strain Gauge and Photo Plethysmograph, D.E.
Hokanson, Inc., Bellevue, Washington, USA). The non-dominant wrist was then fitted
with a small cuff, which was inflated 60 seconds prior to resting blood flow measurement
to a pressure above SBP (200mmHg). Venous blood flow emptying was achieved by
inflating the upper arm cuff to 60mmHg (a pressure below DBP) for intervals of 10
seconds, followed by 5 seconds of deflation. Three resting blood flow measurements
were performed over 1 minute to calculate mean resting blood flow. Following resting
blood flow measurements, forearm ischemia (occlusion of arterial blood flow to the
forearm) was achieved by inflating the cuff on the upper arm to 200mmHg. After 5minutes, the upper arm cuff was released and forearm blood flow was measured every 10
seconds for a total of 60 seconds. Following these measurements, the strain gauge and
wrist cuff was removed from the participant, and his/her arm was lowered to his/her side.
Participants then completed a single bout of IHG as described previously in
Neurovascular Measure 1. Upon completion of this bout, measures of resistance vessel
function were repeated.
Neurovascular Measures #1 and #2 occurred in random order on each testing day
to minimize any potential order effects.
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TESTING DAY 2: Assessment of neurovascular function (indirect assessment of
oxidative stress) prior to and following an acute IHG bout in the non-exercised arm
(Time: 2.5 hours)
Testing Day 2 mirrored Testing Day 1 with the following exception:
neurovascular measures were performed in the non-exercised arm.
TESTING DAY 3: Assessment of neurovascular function (indirect assessment of
oxidative stress) prior to and following an acute IR cuff protocol (Time: 2.5 hours)
Testing Day 3 procedures were identical to Testing Day 1 procedures with the
exception of the acute IHG bout. The acute IHG bout was replaced by a single bout of the
ischemic-reperfusion cuff protocol that mimics the IHG protocol. Participants had an
inflatable cuff (Appendix L; Hokanson Cuff, D.E. Hokanson, Inc., Bellevue, Washington,
USA) positioned on their non-dominant forearm 3cm distal to the olecranon process. A
rapid inflation/deflation cuff was inflated to 200mmHg and held at a constant pressure for
2 minutes to occlude blood flow, after which time the cuff was released, and the
participants then had a 4-minute rest period. This sequence was repeated 4 times in
succession to complete the bout, mimicking the IHG exercise protocol.
Data Analysis
Brachial artery blood flow velocity. Mean blood flow velocity signals postocclusion were recorded from the ultrasound (Vividi, GE Healthcare, Pittsburgh, PA,
USA) using customized software (Stoik Capturer, Moscow, Russia) directly onto a PC
(Dell Optiplex 980, Toronto, Ontario, Canada) as Audio Video Interleave (AVI) files.
AVI files were converted to Waveform Audio (WAV) files for processing. WAV files
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were then processed using customized software to determine mean blood flow velocity
for each QRS interval (Hemodynamic IQ, Windsor, ON, Canada). Mean blood flow
velocity was then analyzed using rolling 3-frame average bins (Thijssen et al., 2011),
within which the peak bin value was ascertained. Each frame corresponded to a single
QRS interval. Resting velocities were recorded for 60-seconds pre-occlusion for later
manual analysis (Vividi, GE Healthcare, Pittsburgh, PA, USA). The average of a 20frame segment was used to determine mean resting blood velocity. The coefficient of
variation for blood velocity using our customized program versus traditional manual
Doppler ultrasound measurements of mean blood velocity in our laboratory is 4.4%.
Brachial artery diameter. Vessel diameter was determined using automated edgedetection software (Artery Measurement System (AMS) v2.0, Gothenburg, Sweden). A
Digital Imaging and Communications in Medicine (DICOM) image was saved at enddiastole for every QRS interval for the entirety of the resting (60 sec) and post-occlusion
(180 sec) recordings and merged into two (resting, post-occlusion) stacked DICOM series
using DICOM editing software (Sante DICOM Editor version 9.10.9200.16721,
Santesoft, Athens, Greece). The stacked DICOM files were then analyzed using AMS
software (Artery Measurement System (AMS) v2.0, Gothenburg, Sweden). This
program allows a user to identify a region of interest along the portion of the vessel
where the near and far walls are clearest. The program collects one diameter measure for
each pixel column within the region of interest and provides a mean diameter for the
entire frame (approximately 100 measurements). All brachial artery diameters were
measured from leading edge to leading edge.
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Figure 2. Assessment of BA diameter using AMS
Resting diameter measures were determined by averaging the 20-frame segment
of diameters corresponding to the segment used to determine resting blood velocity
measures. Brachial artery diameter measures post-release were analyzed using rolling 3frame average bins. This allowed for diameter and velocity measurements to be framealigned at all time points both at rest and post-release (Thijssen et al., 2011).
Both inter- and intra-observer reproducibility were conducted on resting BA
diameter measures as this had yet to be done in our laboratory. The inter-observer
coefficient of variation was calculated using the formula: CV = SD of resting BA
diameter from Investigator 1 & 2 / mean resting BA diameter from investigator 1 & 2 *
100, using measures taken on the CUFF testing day (pre-cuff). Inter-observer method
error was calculated using the formula: ME = SD of the difference between investigator 1
& 2 / Grand Mean * 100, using measures on the CUFF testing day. The inter-observer
correlation coefficient was calculated by correlating the resting BA diameter measures of
investigator 1 with those from investigator 2. Intra-observer reproducibility was
determined using pre-cuff resting BA diameter values from the CUFF testing day

	
  

77	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

compared to those of the EIHG testing day. The coefficient of variation was 2.01%, the
method error was 3.16%, and the correlation coefficient was 0.97 for resting BA diameter
inter-observer reproducibility (Appendix Q). For resting BA diameter intra-observer
reproducibility, the coefficient of variation was 3.10%, the method error was 5.71%, and
the correlation coefficient was 0.97 (Appendix Q).
Resting and peak blood flows. Resting blood flow was determined using the mean
circumference of the artery at rest calculated using mean diameter values (cm) and
resting mean blood velocity values (cm/s). Resting diameter and velocity values were
determined using corresponding 20-frame bin segment means (Thijssen et al., 2011).
The formula used to calculate resting blood velocity was PI * ((mean resting diameter / 2)
^ 2) * mean resting velocity * 60 and the final value was expressed as milliliters per
minute (ml/min). Peak blood flow was determined using the peak circumference of the
artery calculated using peak diameter values (cm) and peak mean blood velocity values
(cm/s). Peak diameter and mean blood velocity values were determined using
corresponding 3-frame bin segment means (Thijssen et al., 2011). The formula used to
calculate peak blood velocity was PI * ((mean resting diameter / 2) ^ 2) * mean peak
blood velocity * 60 and the final value was expressed as milliliters per minute (ml/min).
Flow mediated dilation. Absolute flow mediated dilation, expressed in
millimeters, was calculated using the formula: FMD (mm) = Peak Diameter - Baseline
Diameter, where peak diameter was the highest 3-frame bin post-occlusion and baseline
diameter was the mean of 20 frames recorded pre-occlusion on the ultrasound (Vividi,
GE Healthcare, Pittsburgh, PA, USA). Relative flow mediated dilation was calculated
using the formula: FMD (%) = [Peak Diameter - Baseline Diameter] / Baseline
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Diameter*100, and reported as percentage change (Corretti et al., 2002). FMD was also
normalized using shear rate area under the curve and reported as such. The formula used
for normalization was FMD (%) / AUC(s^-1)*1000 (Pyke & Tschakovsky, 2007). It is
important to note that normalized FMD to AUC should only be considered if there is at
least a consistent, moderate correlation among measures across all research settings
(Thijssen et al., 2011). A consistent, moderate correlation was not found within this
study.
Shear rate area under the curve. Shear rate area under the curve (AUC) was
calculated using velocity and diameter values derived as outlined above. Shear rate for
each rolling 3-frame bin segment was calculated using the formula: 8*mean blood
velocity / diameter (Harris et al., 2010). Shear rates were calculated from cuff release
until peak diameter, signifying peak dilation. Shear rates were graphed over the time
interval from cuff release to peak dilation, and AUC was calculated using a macro within
the statistical software (SigmaPlot 11.0, Systat Software Inc, San Jose, California).
Resistance vessel function. Resistance vessel function was determined using
venous strain-gauge plethysmography. All data were recorded using PowerLab hardware
(ML870 PowerLab 8/30) onto LabChart 7 Pro v7.3.7 (ADInstruments, Colorado Springs,
CO) on a PC (Dell Optiplex 980, Toronto, Ontario, Canada). The slope of the flow over
the first three cardiac cycles for each baseline blood flow curve was determined for each
of three measures, and these slopes were then averaged, to determine mean baseline
blood flow. After 5-minutes of complete occlusion (200 mmHg), one measure of peak
blood flow was recorded. The slope of the first 3 cardiac cycles of the first blood flow
curve was recorded as the peak blood flow post-occlusion and used for analysis.
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Resistance vessel function, expressed as percentage change, was then calculated using the
formula: RVF = [Peak Flow - mean Baseline Flow] / mean Baseline Flow * 100. The
intra-observer reproducibility of resistance vessel endothelial function in our laboratory
is: 6.6 % (coefficient of variation), 2.2 % (method error), and 0.92 (correlation
coefficient). The inter-observer reproducibility of resistance vessel endothelial function
in our laboratory is: 4.3 % (coefficient of variation), 10.4 % (method error), and 0.93
(correlation coefficient) (Badrov et al., 2013a).
See Appendix O for raw data.
Statistical Analysis
Baseline data was analyzed using one-way analysis of variance (ANOVA) to
determine if there were baseline differences between testing days. Outcome data were
analyzed using two-way (Time X Exercise) ANOVA with repeated measures. Tukey
post hoc procedures were used to evaluate specific differences between means where
applicable (SigmaPlot, v.11.0). An alpha level of < 0.05 was considered statistically
significant. Data are presented as mean ± standard deviation (SD), unless otherwise
specified. See Appendix P for detailed statistical analysis.
2.4 Results
Participant baseline characteristics are displayed in Table 1. During active
recruitment over a period of 6 months, 10 males and 26 females expressed interest in
participating in the study. Of those expressing interest, 6 males and 17 females scheduled
an initial visit. Due to inclusion and/or exclusion criteria (medication use, activity levels,
health status), 4 males and 6 females were deemed ineligible during the initial visit, and
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one further male was deemed ineligible during the second visit. Further, 3 females
voluntarily withdrew, and an additional female and 2 males did not attend their scheduled
visits. Given a final participant total of 7 females, but only a single male, the male data
was excluded from further statistical analyses. Primary barriers to participation included
medication use, the opportunity cost of time away from work, and the duration of testing
days. There were no reported changes in exercise, diet, and/or medication throughout the
investigation among all participants. Further, there were no statistically significant
differences in baseline SBP, DBP, MAP, HR, pre-exercise resting blood flow, preexercise peak blood flow, or brachial artery diameters on any of the testing days (all p >
0.05). However, baseline FMD and RVF were not strongly correlated between the CUFF
and EIHG testing days indicating day-to-day variability within these measures.
Table 1. Participant characteristics
Male

Female

N

1

7

Age (years)

63

65 ± 5

Height (cm)

180

161 ± 6

Weight (kg)

74

68 ± 8

BMI

23

26 ± 4

Resting SBP (mmHg)

103 ± 13

100 ± 10

Resting DBP (mmHg)

68 ± 7

60 ± 5

Resting MAP (mmHg)

80 ± 8

74 ± 5

Resting HR (BPM)
60 ± 5
69 ± 5
SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial blood
pressure; HR, heart rate. Values are mean ± SD. All p > 0.05.

	
  

81	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

Resting Mean Blood Flow and Peak Mean Blood Flow
There were no significant differences in resting mean blood flow between
exercise days either pre-, or post-, exercise intervention (Table 2). Likewise, there were
no significant differences in peak mean blood flow between exercise days either pre, or
post, exercise intervention (Table 2). Further, there were no significant differences in
baseline of peak BA diameter measurements between testing days.
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Table 2. Vascular reactivity following exercise intervention (n = 7)
CUFF

EIHG

NEIHG

Pre

32.52 ± 20.52

34.10 ± 18.41

33.73 ± 15.11

Post

31.31 ± 26.46

36.51 ± 12.04

25.19 ± 7.06

Pre

2.89 ± 0.34

2.94 ± 0.48

3.10 ± 0.31

Post

2.92 ± 0.40

2.93 ± 0.31

3.05 ± 0.38

22.64 ± 12.46

21.29 ± 4.11

18.86 ± 6.67

22.38 ± 18.67

26.75 ± 15.26

15.31 ± 4.07

Pre

419.26 ± 168.53

464.05 ± 206.80

422.73 ± 100.02

Post

380.47 ± 87.60

446.45 ± 135.66

470.94 ± 174.39

Pre

3.20 ± 0.40

3.47 ± 0.75

3.40 ± 0.31

Post

3.12 ± 0.31

3.32 ± 0.55

3.28 ± 0.29

Pre

239.34 ± 80.10

219.87 ± 52.35

207.62 ± 38.82

Testing Day
Resting MBF (cm/s)

Resting BA Diameter (mm)

Resting SR (s-1)

Pre
Post

Peak MBF (cm/s)

Peak BA Diameter (mm)

Peak SR (s-1)

Post
229.42 ± 40.67
234.78 ± 45.82
238.23 ± 55.49
CUFF, ischemic-reperfusion cuff testing day; EIHG, isometric handgrip testing day with
vascular measures on the exercised arm; NEIHG, isometric handgrip testing day with
vascular measures on the non-exercised arm; Pre, pre exercise/cuff intervention; Post,
post exercise/cuff intervention; MBF, mean blood flow; BA, brachial artery; BF, blood
flow; SR, shear rate. Values are mean ± SD.	
  All p > 0.05.

	
  

83	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

Flow Mediated Dilation
There were no significant differences noted in relative FMD post-exercise in any
of the three exercise bouts (Table 3). See Appendix R for FMD scatter plots by testing
day. Normalization of relative FMD to shear rate AUC also showed no significant
differences post-exercise for any of the three exercise bouts (Table 3). Additionally,
there were no significant differences in shear rate AUC post-bout on any of the testing
days.
Table 3. Flow mediated dilation following exercise interventions (n = 7)
CUFF

EIHG

NEIHG

Pre

10.86 ± 6.94

13.76 ± 11.74

8.41 ± 7.01

Post

8.89 ± 8.62

13.32 ± 13.4

7.74 ± 5.12

Pre

4316.96 ±
2759.36

4177.18 ± 2408.96

2494.96 ±
3027.78

Post

3392.90 ±
2409.29

4416.80 ± 2359.98

3286.47 ±
1682.01

Pre

3.25 ± 2.08

5.14 ± 4.65

7.08 ± 7.95

Testing Day
Relative FMD (% change)

SR AUC (s^-1)

Normalized FMD
(FMD:AUC)

Post
3.57 ± 3.05
4.01 ± 3.85
2.61 ± 2.18
CUFF, ischemic-reperfusion cuff testing day; EIHG, isometric handgrip testing day with
vascular measures on the exercised arm; NEIHG, isometric handgrip testing day with
vascular measures on the non-exercised arm; Pre, pre exercise/cuff intervention; Post,
post exercise/cuff intervention; FMD, flow-mediated dilation; SR, shear rate; AUC, area
under curve. Values are mean ± SD. All p > 0.05.

	
  

84	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

Resistance Vessel Function
There were no significant differences noted in resistance vessel function postexercise in each of the three exercise interventions (Table 4). See Appendix R for RVF
scatter plots by testing day.
Table 4. Resistance vessel function following exercise interventions (n = 6*)
Testing Day
RVF (% change)

Pre

CUFF

EIHG

NEIHG

1107.16 ±
742.27

447.30 ± 283.93

505.35 ± 326.12

Post 753.44 ± 434.06
333.49 ± 228.80
859.0 ± 290.93
CUFF, ischemic-reperfusion cuff testing day; EIHG, isometric handgrip testing day with
vascular measures on the exercised arm; NEIHG, isometric handgrip testing day with
vascular measures on the non-exercised arm; Pre, pre exercise/cuff intervention; Post,
post exercise/cuff intervention; RVF, resistance vessel function. Values are mean ± SD.
All p > 0.05. * One participant was removed from statistical analysis as data was missing
due to equipment malfunction.
2.5 Discussion
HT is a major modifiable risk factor for the development of CVD (WHO, 2013).
Recently, the World Health Organization has identified HT as a global epidemic (WHO,
2013). IHG training is an effective means of lowering resting arterial BP in numerous
populations (McGowan et al., 2006; McGowan et al., 2007a; McGowan et al., 2007b;
Taylor et al., 2003; Millar et al., 2009; Badrov et al., 2013a). Interestingly, older females
with normal resting arterial BP appear to respond to IHG with greater post-training
reductions in resting arterial BP than age-matched males (Millar et al., 2008). The
mechanism(s) underlying the reduction in resting arterial BP due to IHG training are
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currently unknown. It has been proposed that transient exposure to oxidative stress, due
to IR induced by the IHG contraction, may promote an adaptive response and an
increased basal antioxidant capacity (Peters et al., 2006). This increased basal
antioxidant capacity more readily neutralizes oxidative free radicals, increasing the
bioavailability of NȮ, improving endothelial function and potentially lowering resting
arterial BP. Due to poor recruitment of male participants, this study was unable to
address possible sex differences described in the initial hypotheses. However, this is the
first study conducted to explore IR as an underlying mechanism modulating resting
arterial BP in response to IHG exercise. Further, this is the first study to compare acute
IHG exercise to IR induced by a simple cuff.
2.5.1 Effects of an Acute Bout of IHG Exercise on Vascular Reactivity in the
Exercised Arm
No significant differences were found in FMD, normalized FMD, or resistance
vessel function (RVF), indicating that an acute bout of IHG did not significantly alter
vascular reactivity in the exercised arm. However, there were consistent mean trends in
the data. Mean vascular reactivity in the exercised arm was suppressed post-IHG
exercise when assessed via FMD (13.76 ± 11.74% to 13.32 ± 13.40%), normalized FMD
(5.14 ± 4.65 to 4.01 ± 3.85), and RVF (447.30 ± 283.93% to 333.49 ± 228.80%). The
acute IHG exercise protocol used in this investigation was unilateral in the non-dominant
arm, with 4-minutes rest between contractions. In contrast, the protocol used by Peters
and colleagues (2006) was a bi-lateral protocol with 1-minute rest between contractions.
As such, the added 3-minutes of rest after the final contraction before post-IHG testing
may have functioned as a washout period reducing the possibility of noting any changes
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in vascular reactivity. Alternatively, it is possible that the limited number of participants
(n=7), and their degree of inter-individual variation, did not allow for adequate power to
detect significant changes in vascular reactivity following an acute IHG bout.
The potential also exists that the acute bout of IHG exercise used in this study did
not provide a stimulus strong enough to elicit an acute state of oxidative stress. If the
basal antioxidant capacity of the participants was not exceeded it is conceivable that NȮ
bioavailability may not have been decreased enough to elicit a significant change in acute
vascular reactivity. However, if this were indeed true, it would diminish the possibility
that modulations in basal antioxidant capacity due to repeated bouts of acute IHG
exercise is a mechanism underlying the resting arterial BP response to IHG training.
Nonetheless, further investigation with increased power is necessary.
2.5.2 Effects of an Acute Bout of IHG Exercise on Vascular Reactivity in the NonExercised Arm
Similar to that observed after an acute IHG bout in the exercised arm, no
significant differences were found in FMD normalized FMD, or RVF in the nonexercised arm. However, while FMD (8.41 ± 7.01% to 7.74 ± 5.12%), and normalized
FMD (7.08 ± 7.95 to 2.61 ± 2.18), both trended down in a similar direction to that of the
exercised arm, RVF (505.35 ± 326.12% to 859.00 ± 290.93%) did not follow this trend
Peak MBF, an indirect index of RVF, also increased post IHG bout in the nonexercised arm mirroring the RVF measure. This provides further support for the
observation that an acute IHG exercise bout did not decrease vascular reactivity in the
RVF of the non-exercised arm. As described previously, the acute IHG exercise protocol
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used in this investigation was unilateral in the non-dominant arm, with 4-minutes rest
between contractions. The added 3-minutes of rest between the final contraction and
vascular reactivity testing may function as a washout period, reducing the possibility of
noting any changes.
Given that FMD is an indicator of vascular reactivity in the larger conduit arteries
(Corretti et al., 2002), and RVF is an indicator of vascular reactivity in the smaller
downstream vessels (Higashi & Yoshizumi, 2003), it is possible that the stimulus strength
was lower in the non-exercised arm and thus did not effect the downstream resistance
vessels as potently. If an acute bout of IHG exercise does indeed elicit localized IR and,
in turn, localized oxidative stress, it is possible that these excess free radicals are
neutralized before reaching the distal resistance vessel of the contralateral arm. However,
this may indicate that an acute bout of IHG exercise does not elicit a systemic effect, at
least not at the level of the resistance vessel, putting into question their role in the known
resting arterial BP response to IHG exercise.
Furthermore, the role of arm dominance cannot be discounted when comparing
the response to an acute IHG bout. As all exercise was conducted in the non-dominant
arm, vascular reactivity on this testing day was measured in the dominant arm. It is
possible that, due to favoured use over the lifespan, the dominant arm is relatively more
trained than the non-dominant arm. As such, the stimulus provided by the acute IHG
bout in the non-dominant arm may have not been strong enough to elicit any changes in
vascular reactivity in the dominant arm. As touched on previously, the variability
between the small number of participants (n=7) makes it difficult to draw clear
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conclusions. Nonetheless, the difference in trends of vascular reactivity in the exercise
and non-exercised arms does provide interesting theoretical implications.
2.5.3 Effects of an Acute Bout of Ischemic-Reperfusion on Vascular Reactivity in the
Reperfused Arm
In response to a bout of IR mimicking the timing and duration of the IHG
protocol there were no significant differences observed in vascular reactivity measured in
the arm of reperfusion. Although not statistically significant, both FMD (10.86 ± 6.94 to
8.89 ± 8.62) and RVF (1107.16 ± 742.27% to 753.44 ± 434.06%) decreased post-IR as
observed in the exercised arm after a bout of IHG. Interestingly, once FMD was
normalized to shear rate area under the curve this trend was reversed (3.25 ± 2.08 to 3.57
± 3.05). However, as previously stated, normalization of FMD to AUC should only be
considered when there is at least a correlation across all research settings (Thijssen et al.,
2011). Given that a consistent, moderate correlation did not exist between these
measures in this study relative FMD would be a more applicable index of vascular
reactivity (See Appendix P).
The IR protocol applied in this investigation used an inflation pressure of 200
mmHg, a pressure significantly above SBP, to ensure full occlusion of the lower arm. As
such, this stimulus may be stronger than that of an acute IHG bout as IHG does not elicit
ischemia progressively until 30% MVC and above (Sadamoto et al., 1983; Sakakibara &
Honda, 1990). It is therefore conceivable that oxidative stress would be increased to a
greater degree via the cuff than that of the IHG, leading to greater reductions in vascular
reactivity after IR induced by a cuff. However, a lack of significance does not allow for
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meaningful comparison. Although the direction of mean changes between the cuff and
the acute IHG bout in the exercised arm are similar, a lack of statistical significance,
likely due to a lack of power, does not allow for adequate comparison.
The position of the IR cuff used to mimic the acute IHG bout in this study was
located on the forearm. The rationale behind this placement was that muscular
contraction during a bout of IHG is primarily in the forearm, however contributions from
the muscles of the upper arm cannot be ruled out. If the IR cuff was placed above the
elbow, eliciting occlusion and reperfusion of a greater tissue volume as well as part of the
brachial artery, it is likely that the stimulus strength would be higher, which may produce
differing results. An interesting direction of future research would be the comparison of
various IR cuff pressures and positions to an IHG exercise bout to determine relative
equivalencies. This would allow for more direct IR stimulus comparisons.
2.6 Perspectives
A number of interesting and important concepts were explored within this project,
including the acute effects of a bout of IHG exercise, the role of IR as a potential
mechanism underlying resting arterial BP changes in response to IHG exercise, and the
systemic effects of an acute bout of IHG exercise. Further, the difficulties in studying
this specific population were identified for future investigations. Participant recruitment
was of particular difficulty predominantly due to the medical status of most individuals
within this population as well as the time commitment necessary to complete the study.
Post hoc sample size analysis determined a sample size range of 5 to 217, depending on
the variable, to reach statistical significance. Future studies should attempt to quantify IR
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stimuli relative to IHG contraction strengths to determine relative equivalencies, compare
an equivalent IR stimuli to the most common IHG exercise protocols in the training
literature, including the most common bilateral protocol which employs minimal rest
between contractions, investigate potential differences in vascular reactivity after an
acute bout of IHG in the exercised and non-exercised arms to determine systemic effects,
and investigate IR training to determine if resting arterial BP would decrease similar to
that observed after IHG training. As the limited male participant recruitment of this
study did not allow for a sex-based comparison, the response to an acute bout of IHG
between sexes should also be investigated.
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Appendix A: Informed Consent

CONSENT TO PARTICIPATE IN RESEARCH
Title of Study: Gender differences in the neurovascular response to
acute isometric handgrip exercise and a complimentary ischemicreperfusion cuff protocol
You are asked to participate in a research study conducted by Josh Seifarth,
BHk, & Dr. Cheri McGowan, PhD, from the Department of Kinesiology at
the University of Windsor.
If you have any questions or concerns about the research, please feel to
contact Josh Seifarth via telephone (519-253-3000 ext. 4979).
PURPOSE OF THE STUDY
Hypertension increases the risk of cardiovascular disease. Isometric
handgrip exercise (constant squeeze) training is a type of exercise training
that lowers blood pressure (BP) in people with and without high BP. The
goal of this study is to see if men and women respond differently (i.e., blood
pressure, heart rate, blood vessels) to a single bout of handgrip exercise. We
will also see if inflating a cuff around your lower arm will have the same
results as a single bout of handgrip exercise.
Familiarization Session (30 minutes):
In the familiarization session, you will be introduced to all the techniques
that will be used in this study. To minimize anything that may influence
results, we will ask you to refrain from the consumption of alcohol and
participation in vigorous exercise for 24 hours prior to each testing session,
and to avoid caffeine consumption for 12 hours prior. Further, we ask that
you refrain from eating for 4 hours prior to all testing sessions. All testing
will be conducted in a quiet, temperature-controlled room at the same time
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of day. You will be asked to void their bladder prior to all testing sessions to
minimize the effects of a full bladder on resting BP.
The following testing days will be conducted in random order, and the
testing measures within each day will also be in random order.
Testing Day 1 (approximately 3 hours):
First, your resting blood pressure will be measured in your upper arm after
10 minutes of seated rest. Your blood pressure will be measured 4 times,
with 2-minutes of rest between measures. This will repeated again at least
24-hours after Testing Day 1.
Next, while remaining seated, a blood pressure cuff will be placed on your
non-dominant forearm. A technique called flow-mediated dilation will be
used on your upper arm to measure the size of your artery and the speed of
blood flowing through it. To do this a probe with ultrasound gel will be
placed on your upper arm. The cuff on your forearm will be inflated to
~200mmHg for 5 minutes and then released. Next, you will engage in 4
bouts of handgrip exercise in your non-dominant arm comprising 2-minute
squeezes with 4-minute breaks between each. Following the exercise,
measures of artery size and blood flow will be repeated. You will then lie
on your back for 30 minutes of rest.
After 30 minutes of rest, blood vessel function will be measured using a
technique called venous strain-gauge plethysmography. In this procedure,
your non-dominant arm will be elevated above heart level and a rubber
strain gauge (similar to an elastic) will be placed around the largest part of
your forearm. A cuff will be placed on your wrist and will be inflated to a
pressure above systolic BP (generally close to 200mmHg). The cuff on your
upper arm will be inflated for 10 seconds and then released for 5 seconds,
and this will continue for 1 minute. Next, the upper arm cuff will be inflated
to 200mmHg for 5 minutes and then released. Forearm blood flow will be
measured every 10 seconds for 1 minute after the cuff is released. You will
then engage in 4 bouts of handgrip exercise in your non-dominant arm
comprising 2-minute squeezes with 4-minute breaks between each.
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Following the exercise, the blood vessel function technique will be repeated
as described above.
Testing Day 2 (approximately 3 hours):
Testing Day 2 will mirror Testing Day 1 with the following exception:
testing measures will be performed in the non-exercised limb. You will
exercise using the same arm as Testing Day 1 (non-dominant arm), but we
will measure all of our variables in your non-exercising arm (dominant arm).
Testing Day 3 (approximately 3 hours):
Testing Day 3 Procedures are identical to Testing Day 1 procedures with the
exception of the hand-grip bout. The hand-grip bout will be replaced by a
single bout of cuff inflation and deflation. You will have an inflatable cuff
positioned on your non-dominant forearm below the elbow. The cuff will be
inflated above systolic BP and held at a constant pressure for 2 minutes,
after which time the cuff will be released for 4 minutes. This sequence will
be repeated 4 times in a row to complete the bout so to mimic what occurs
during the hand grip exercise. This protocol should produce minimal
discomfort as the duration and pressure is well below what has been found to
cause even low discomfort.
POTENTIAL RISKS AND DISCOMFORTS
You may experience tendonitis in the tendons of the exercising arms with
handgrip exercise however this risk is minimal if the exercise is properly
performed. The blood pressure and blood flow measurement procedures are
non-invasive but you may experience numbness and/or tingling in the limb
with the cuff(s) while we are taking our measurements. The gel used to
image your blood vessels and/or the sticker-electrodes used to measure your
heart rate may cause a skin irritation however, this risk is minimal.
Please contact one of the study investigators if you feel any adverse effects
from completing any portion of the study, and/or if you have any questions
or concerns. Exercise leaders and study investigators will reinforce proper
exercise technique throughout the study. If you experience any adverse
effects during any testing procedure, first line response will be provided.
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POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
You may or may NOT experience a lower blood pressure at rest or during
your activities of daily life after each part of the study. In addition, you may
or may not have improvements in the ability of your heart to vary its rhythm,
a decrease in the activity of your nervous system, reduced tension in certain
blood vessels of your body, an increase in the efficiency of the work of your
heart, and/or reduced oxidative stress.
If we prove our theories, isometric handgrip training may be a possible
prevention and/or treatment option for older males and females, like you.
PAYMENT FOR PARTICIPATION
You will receive a Human Kinetics T-shirt for your participation, and will be
reimbursed for health care provider forms and/or parking costs over the
course of the study.
CONFIDENTIALITY
Any information that is obtained in connection with this study and that can
be identified with you will remain confidential and will be disclosed only
with your permission.
To ensure your confidentiality, following your consent, you will be assigned
an identification number. Your name will not be mentioned in any
publication or presentation, and you will be identified with only your
identification number on all collection tools (electronic or otherwise). All
paper data and all electronic data will be stored in the locked laboratory
(PACR Lab, Room #240, Human Kinetics Building, University of Windsor)
of the study investigators. Information stored on computer will be passwordaccessible only. With respect to final disposal, all paper records (including
medical and physical activity readiness questionnaires) will be shredded.
PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not. If you volunteer to be in
this study, you may withdraw at any time without consequences of any kind.
You may also refuse to answer any questions you do not wish to answer and
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still remain in the study. The investigator may withdraw you from this
research if circumstances arise which warrant doing so (e.g., medication,
nutrition and/or physical activity change).
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE
PARTICIPANTS
You will have the option of receiving results from the study either verbally,
by mail or email. Results will also be posted on the University of Windsor’s
Research Ethics Board (REB) website (http://www.uwindsor.ca/reb) at the
completion of the study.
SUBSEQUENT USE OF DATA
This data may be used in subsequent studies however your privacy will be
upheld with the use of your unique subject identification number under all
circumstances.
RIGHTS OF RESEARCH PARTICIPANTS
You may withdraw your consent at any time and discontinue participation
without penalty. If you have questions regarding your rights as a research
subject, contact: Research Ethics Coordinator, University of Windsor,
Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext. 3948; e mail:
ethics@uwindsor.ca
SIGNATURE OF RESEARCH PARTICIPANT/LEGAL
REPRESENTATIVE
I understand the information provided for the study: Gender differences in
the vascular response to acute IHG exercise as described herein. My
questions have been answered to my satisfaction, and I agree to participate
in this study. I have been given a copy of this form.

___________________________________
Name of Participant
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___________________________________

______________

Signature of Participant

Date

SIGNATURE OF INVESTIGATOR
These are the terms under which I will conduct research.
___________________________________
Signature of Investigator

____________________
Date

Version Date: 03/12/13
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Appendix B: LETTER OF INFORMATION

LETTER OF INFORMATION
Title of Study: Gender differences in the neurovascular response to
acute isometric handgrip exercise and a complimentary ischemicreperfusion cuff protocol
You are asked to participate in a research study conducted by Josh Seifarth,
BHk, & Dr. Cheri McGowan, PhD, from the Department of Kinesiology at
the University of Windsor.
If you have any questions or concerns about the research, please feel to
contact Josh Seifarth via telephone (519-253-3000 ext. 4979).
PURPOSE OF THE STUDY
Hypertension increases the risk of cardiovascular disease. Isometric
handgrip exercise (constant squeeze) training is a type of exercise training
that lowers blood pressure (BP) in people with and without high BP. The
goal of this study is to see if men and women respond differently (i.e., blood
pressure, heart rate, blood vessels) to a single bout of handgrip exercise. We
will also see if inflating a cuff around your lower arm will have the same
results as a single bout of handgrip exercise.
Familiarization Session (30 minutes):
In the familiarization session, you will be introduced to all the techniques
that will be used in this study. To minimize anything that may influence
results, we will ask you to refrain from the consumption of alcohol and
participation in vigorous exercise for 24 hours prior to each testing session,
and to avoid caffeine consumption for 12 hours prior. Further, we ask that
you refrain from eating for 4 hours prior to all testing sessions. All testing
will be conducted in a quiet, temperature-controlled room at the same time
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of day. You will be asked to void their bladder prior to all testing sessions to
minimize the effects of a full bladder on resting BP.
The following testing days will be conducted in random order, and the
testing measures within each day will also be in random order.
Testing Day 1 (approximately 3 hours):
First, your resting blood pressure will be measured in your upper arm after
10 minutes of seated rest. Your blood pressure will be measured 4 times,
with 2-minutes of rest between measures. This will repeated again at least
24-hours after Testing Day 1.
Next, while remaining seated, a blood pressure cuff will be placed on your
non-dominant forearm. A technique called flow-mediated dilation will be
used on your upper arm to measure the size of your artery and the speed of
blood flowing through it. To do this a probe with ultrasound gel will be
placed on your upper arm. The cuff on your forearm will be inflated to
~200mmHg for 5 minutes and then released. Next, you will engage in 4
bouts of handgrip exercise in your non-dominant arm comprising 2-minute
squeezes with 4-minute breaks between each. Following the exercise,
measures of artery size and blood flow will be repeated. You will then lie
on your back for 30 minutes of rest.
After 30 minutes of rest, blood vessel function will be measured using a
technique called venous strain-gauge plethysmography. In this procedure,
your non-dominant arm will be elevated above heart level and a rubber
strain gauge (similar to an elastic) will be placed around the largest part of
your forearm. A cuff will be placed on your wrist and will be inflated to a
pressure above systolic BP (generally close to 200mmHg). The cuff on your
upper arm will be inflated for 10 seconds and then released for 5 seconds,
and this will continue for 1 minute. Next, the upper arm cuff will be inflated
to 200mmHg for 5 minutes and then released. Forearm blood flow will be
measured every 10 seconds for 1 minute after the cuff is released. You will
then engage in 4 bouts of handgrip exercise in your non-dominant arm
comprising 2-minute squeezes with 4-minute breaks between each.
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Following the exercise, the blood vessel function technique will be repeated
as described above.
Testing Day 2 (approximately 3 hours):
Testing Day 2 will mirror Testing Day 1 with the following exception:
testing measures will be performed in the non-exercised limb. You will
exercise using the same arm as Testing Day 1 (non-dominant arm), but we
will measure all of our variables in your non-exercising arm (dominant arm).
Testing Day 3 (approximately 3 hours):
Testing Day 3 Procedures are identical to Testing Day 1 procedures with the
exception of the hand-grip bout. The hand-grip bout will be replaced by a
single bout of cuff inflation and deflation. You will have an inflatable cuff
positioned on your non-dominant forearm below the elbow. The cuff will be
inflated above systolic BP and held at a constant pressure for 2 minutes,
after which time the cuff will be released for 4 minutes. This sequence will
be repeated 4 times in a row to complete the bout so to mimic what occurs
during the hand grip exercise. This protocol should produce minimal
discomfort as the duration and pressure is well below what has been found to
cause even low discomfort.
POTENTIAL RISKS AND DISCOMFORTS
You may experience tendonitis in the tendons of the exercising arms with
handgrip exercise however this risk is minimal if the exercise is properly
performed. The blood pressure and blood flow measurement procedures are
non-invasive but you may experience numbness and/or tingling in the limb
with the cuff(s) while we are taking our measurements. The gel used to
image your blood vessels and/or the sticker-electrodes used to measure your
heart rate may cause a skin irritation however, this risk is minimal.
Please contact one of the study investigators if you feel any adverse effects
from completing any portion of the study, and/or if you have any questions
or concerns. Exercise leaders and study investigators will reinforce proper
exercise technique throughout the study. If you experience any adverse
effects during any testing procedure, first line response will be provided.
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POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
You may or may NOT experience a lower blood pressure at rest or during
your activities of daily life after each part of the study. In addition, you may
or may not have improvements in the ability of your heart to vary its rhythm,
a decrease in the activity of your nervous system, reduced tension in certain
blood vessels of your body, an increase in the efficiency of the work of your
heart, and/or reduced oxidative stress.
If we prove our theories, isometric handgrip training may be a possible
prevention and/or treatment option for older males and females, like you.
PAYMENT FOR PARTICIPATION
You will receive a Human Kinetics T-shirt for your participation, and will be
reimbursed for health care provider forms and/or parking costs over the
course of the study.
CONFIDENTIALITY
Any information that is obtained in connection with this study and that can
be identified with you will remain confidential and will be disclosed only
with your permission.
To ensure your confidentiality, following your consent, you will be assigned
an identification number. Your name will not be mentioned in any
publication or presentation, and you will be identified with only your
identification number on all collection tools (electronic or otherwise). All
paper data and all electronic data will be stored in the locked laboratory
(PACR Lab, Room #240, Human Kinetics Building, University of Windsor)
of the study investigators. Information stored on computer will be passwordaccessible only. With respect to final disposal, all paper records (including
medical and physical activity readiness questionnaires) will be shredded.
PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not. If you volunteer to be in
this study, you may withdraw at any time without consequences of any kind.
You may also refuse to answer any questions you do not wish to answer and
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still remain in the study. The investigator may withdraw you from this
research if circumstances arise which warrant doing so (e.g., medication,
nutrition and/or physical activity change).
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE
PARTICIPANTS
You will have the option of receiving results from the study either verbally,
by mail or email. Results will also be posted on the University of Windsor’s
Research Ethics Board (REB) website (http://www.uwindsor.ca/reb) at the
completion of the study.
SUBSEQUENT USE OF DATA
This data may be used in subsequent studies however your privacy will be
upheld with the use of your unique subject identification number under all
circumstances.
RIGHTS OF RESEARCH PARTICIPANTS
You may withdraw your consent at any time and discontinue participation
without penalty. If you have questions regarding your rights as a research
subject, contact: Research Ethics Coordinator, University of Windsor,
Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext. 3948; e mail:
ethics@uwindsor.ca

Version Date: 03/12/13
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Appendix C: Medical Questionnaire
	
  
Last Name _______________________________________________

First Name _____________________________________

Height:_______________________ Weight: _______________________ Date of Birth (Month/Yr) _______
Phone (

) _______________________________________ Postal Code ____________________

FOR EMERGENCY NOTIFY: Name ___________________ Relationship ________________________________________

Address__________________________________________________________ Phone _________________________________
Family Doctor's Name_______________________________________

Date of Last Physical _____________________________

Please Check Yes or No:
Yes No
1.

Have you ever been hospitalized? ............................................................................................................................ ❏ ❏
If yes, please specify?
_______________________________________________________________________________________

Have you ever had surgery? ..................................................................................................................................... ❏ ❏
If yes, please specify?
_______________________________________________________________________________________

2. Are you presently taking any medications or pills (including aspirin and other over-the-counter
medication)?
❏❏
If yes, please specify?
_______________________________________________________________________________________

Are you presently taking any vitamins, supplements, and/or herbal supplements? .................................................. ❏ ❏
3.

Do you have any allergies (medicine, food, bees or other stinging insects)? ............................................................ ❏ ❏
If yes, please specify?

_______________________________________________________________________________________

4.

Have you ever passed out during or after exercise? ................................................................................................. ❏ ❏
Have you ever been dizzy during or after exercise? ................................................................................................. ❏ ❏
Have you ever had chest pain during or after exercise? ........................................................................................... ❏ ❏
Do you have high blood pressure (hypertension) or low blood pressure (hypotension)? .......................................... ❏ ❏
Have you ever been told that you have a kidney problem? ...................................................................................... ❏ ❏
Have you ever been told that you have joint instability? ........................................................................................... ❏ ❏
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Have you ever been told that you have a stomach problem? ................................................................................... ❏ ❏
Have you ever been told that you have a heart problem? ........................................................................................ ❏ ❏
Have you ever been told that you have a heart murmur? .......................................................................................... ❏ ❏
Do you have a machine that regulated your heart beat? .......................................................................................... ❏ ❏
Have you ever had racing of your heart or skipped heartbeats? ............................................................................... ❏ ❏
Has anyone in your family died of heart problems or a sudden death before age 50? ............................................. ❏ ❏
5.

Do you have any skin problems (itching, rashes, acne)? .......................................................................................... ❏ ❏
If you get a cut, does it take you a long time to stop bleeding? ................................................................................. ❏ ❏
If you experience a blow to a muscle, to you bruise easily? ..................................................................................... ❏ ❏
......................................................................................................................................... ❏ ❏

6.

Do you have Diabetes?

7.

Do you have Asthma or any other breathing problems?

..................................................................................... ❏ ❏

If yes, please specify?
_______________________________________________________________________________________

8.

Do you have any type of cardiovascular disease? .................................................................................................... ❏ ❏

If yes, please
specify?_______________________________________________________________________________________
9.

Have you had any other medical problems (infectious mononucleosis, etc.)? .......................................................... ❏ ❏

10. Have you had any medical problems since your last physical? ................................................................................ ❏ ❏
11. Do you smoke?

......................................................................................................................................... ❏ ❏

12. Do you aerobically exercise (e.g., walking) for > 30 minutes, > 2 times per week? ................................................. ❏ ❏
Please explain any physical limitations that may prevent you from completing this study:
__________________________________________________________________________________________________
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Appendix D: Resting BP Device

Dinamap Carescape v100, Critikon, Tampa, Florida, USA
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Appendix E: Physical Activity Readiness Medical Examination (PAR MED-X)

	
  

110	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

Appendix F: Physical Activity Readiness Questionnaire (PAR-Q)
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Appendix G: Healthcare Provider Form

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  	
  	
  	
  	
  	
  

Date:	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  .	
  
	
  
Dear	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  ,	
  
	
  
Your	
  patient,	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  ,	
  has	
  expressed	
  
interest	
  in	
  participating	
  in	
  our	
  research	
  study	
  in	
  the	
  Department	
  of	
  
Kinesiology	
  at	
  the	
  University	
  of	
  Windsor	
  entitled:	
  	
  Gender	
  differences	
  in	
  the	
  
vascular	
  response	
  to	
  acute	
  IHG	
  exercise	
  (see	
  attached	
  Letter	
  of	
  Information	
  
for	
  Consent	
  for	
  details).	
  	
  If	
  you	
  approve	
  your	
  patient’s	
  participation	
  in	
  our	
  
study	
  (via	
  PAR-‐medX),	
  we	
  kindly	
  request	
  that	
  you	
  or	
  a	
  representative	
  
inform	
  us	
  of	
  any	
  changes	
  in	
  medically-‐endorsed	
  exercise,	
  nutrition	
  and/or	
  
medication	
  status,	
  as	
  these	
  changes	
  may	
  influence	
  our	
  findings.	
  	
  We	
  ask	
  
that	
  you	
  sign	
  the	
  attached	
  form	
  for	
  return	
  with	
  the	
  PAR	
  Med-‐X	
  to	
  
acknowledge	
  your	
  receipt	
  of	
  this	
  request.	
  
Thank	
  you	
  for	
  your	
  help,	
  and	
  we	
  appreciate	
  your	
  support.	
  	
  Please	
  do	
  not	
  
hesitate	
  to	
  contact	
  us	
  if	
  you	
  have	
  any	
  questions	
  or	
  concerns.	
  
	
  
Sincerely,	
  
Dr.	
  Cheri	
  McGowan,	
  Ph.D	
  
Assistant	
  Professor	
  
Department	
  of	
  Kinesiology	
  
Faculty	
  of	
  Human	
  Kinetics	
  
University	
  of	
  Windsor	
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Appendix H: ECG & PowerLab (Data Recording Device)

Powerlab ML 870/P, AD Instruments, Colorado Springs, Colorado, USA
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Appendix I: Ultrasound Machine

Vivid i, GE Healthcare, Pittsburgh, Pennsylvania, USA
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Appendix J: Isometric Handgrip

ZonaPLUS, Zona HEALTH, Boise, Idaho, USA
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Appendix K: Plethysmography System

Hokanson EC6 Strain Gauge and Photo Plethysmograph, D.E. Hokanson, Inc., Bellevue,
WA, USA
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Appendix L: Hokanson Inflatable Cuff

Hokanson E20 Cuff Inflator, D.E. Hokanson, Inc., Bellevue, Washington, USA
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Appendix M: Recruitment Script & Poster
Local media/newspaper/email recruitment script:
" Attention all men and women over the age of 60 years with normal blood
pressure. You may be eligible to participate in a research study at the University
of Windsor being conducted by Josh Seifarth, BHK and Dr. Cheri McGowan,
PhD. We are investigating the effects of a single bout of isometric handgrip
exercise on your blood pressure, heart rate and blood vessels. For more
information please contact Josh Seifarth at 519-253-3000 ex. 4979
or seifart@uwindsor.ca."
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Josh	
  Seifarth,	
  BHK,	
  and	
  Dr.	
  Cheri	
  McGowan,	
  PhD,	
  at	
  the	
  University	
  of	
  Windsor	
  is	
  
currently	
  looking	
  for	
  individuals	
  over	
  the	
  age	
  of	
  60	
  years	
  with	
  normal	
  blood	
  pressure	
  
to	
  participate	
  in	
  a	
  study	
  examining	
  the	
  effects	
  of	
  isometric	
  handgrip	
  exercise	
  on	
  blood	
  
pressure,	
  heart	
  rate	
  and	
  blood	
  vessels.	
  

If	
  you	
  are	
  interested	
  and	
  would	
  like	
  more	
  information	
  please	
  contact	
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  4979	
  or	
  seifart@uwindsor.ca	
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  has	
  been	
  cleared	
  by	
  the	
  University	
  of	
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  Research	
  Ethics	
  Board	
  
	
  

119	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

Appendix N: Emergency Action Plan (EAP)

EMERGENCY	
  ACTION	
  PLAN	
  (EAP)	
  
FOR	
  MEDICAL	
  EMERGENCIES	
  DURING	
  EXERCISE	
  TESTING	
  

STEP	
  1:	
  	
  

REMAIN	
  CALM.	
  	
  	
  
CONTROL	
  and	
  ASSESS	
  the	
  situation.	
  

	
  
Campus	
  Police	
  EXT.	
  4444	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  OR	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  911	
  
(they	
  will	
  dispatch	
  required	
  authorities)	
  	
  	
  
	
  
OUR	
  ADDRESS/DIRECTIONS:	
  
The	
  University	
  of	
  Windsor	
  
Human	
  Kinetics	
  Building	
  
2555	
  College	
  Ave.	
  
Main	
  Entrance	
  off	
  College	
  Ave.	
  
	
  
Room#	
  240	
  (uppermost	
  floor)	
  
Go	
  in	
  through	
  the	
  m ain	
  doors	
  of	
  the	
  Human	
  Kinetics	
  
Building.	
  There	
  will	
  be	
  doors	
  on	
  the	
  left	
  hand	
  side.	
  Go	
  Up	
  
the	
  stairs,	
  and	
  go	
  to	
  the	
  end	
  of	
  the	
  hallway.	
  Turn	
  left	
  and	
  
walk	
  to	
  the	
  end	
  of	
  the	
  short	
  hallway,	
  turn	
  left,	
  room	
  240	
  
will	
  be	
  the	
  first	
  door	
  on	
  your	
  right	
  hand	
  side.	
  

	
  

	
  

	
  

OUR	
  PHONE#:	
  	
  	
  
519-‐253-‐3000	
  ext.4979	
  

STEP	
  2:	
  	
  

PERFORM	
  all	
  measures	
  (CPR/First	
  Aid)	
  to	
  ensure	
  safety	
  of	
  subject.	
  

	
  

ATTEND	
  to	
  subject	
  until	
  replaced	
  by	
  emergency	
  personnel.	
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Appendix O: Raw Data for Chapter 2
Participant Characteristics
Participant Characteristics
Participant

Age (years)

Sex

Height (cm)

Weight (kg)

BMI (kg/m2)

1

63

M

180.3

73.9

22.7

2

63

F

156.2

72.6

29.8

3

63

F

160.0

67.1

26.2

4

68

F

162.6

65.8

24.9

5

72

F

157.5

53.5

21.6

6

63

F

170.2

65.8

22.7

7

59

F

167.6

73.5

26.2

8

64

F

154.9

79.4

33.1

Resting Systolic Blood Pressure Data (mmHg)
Testing Day

	
  

Participant

IV

FAM

CUFF

E IHG

NE IHG

1

108.0

101.3

122.0

88.3

97.0

2

102.0

97.7

98.3

96.7

95.7

3

102.3

136.0

114.0

96.7

100.3

4

96.3

100.7

84.3

85.0

85.3

5

106.7

94.3

91.3

93.7

90.3

6

99.0

104.3

94.7

98.0

100.3

7

99.3

105.3

100.7

96.7

110.3

8

110.7

101.3

112.3

108.7

105.7
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Resting Diastolic Blood Pressure Data (mmHg)
Testing Day
Participant

IV

FAM

CUFF

E IHG

NE IHG

1

64.7

70.7

78.3

60.7

65.7

2

61.7

60.7

57.7

68.0

64.3

3

56.7

65.3

64.3

54.7

59.0

4

54.3

58.3

54.7

53.3

50.0

5

58.7

57.7

58.3

61.3

55.7

6

63.7

65.3

60.0

62.7

64.0

7

64.0

61.0

62.3

61.3

63.0

8

65.3

70.7

62.3

56.3

57.7

Mean Arterial Pressure Data (mmHg)
Testing Day

	
  

Participant

IV

FAM

CUFF

E IHG

NE IHG

1

79.1

80.9

92.9

69.9

76.1

2

75.1

73.0

71.2

77.6

74.8

3

71.9

88.9

80.9

68.7

72.8

4

68.3

72.4

64.6

63.9

61.8

5

74.7

69.9

69.3

72.1

67.2

6

75.4

78.3

71.6

74.4

76.1

7

75.8

75.8

75.1

73.1

78.8

8

80.4

80.9

79.0

73.8

73.7
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Resting Heart Data (bpm)
Testing Day
Participant

IV

FAM

CUFF

E IHG

NE IHG

1

56.0

69.7

60.0

59.0

57.3

2

77.0

74.7

77.3

75.0

74.0

3

65.3

60.3

64.3

70.0

71.3

4

74.0

76.0

66.7

68.3

69.7

5

74.3

67.3

73.3

70.3

73.3

6

68.7

69.0

74.0

75.0

66.0

7

70.7

62.0

63.0

63.3

68.0

8

62.0

69.7

66.3

58.3

57.3

Resting and Peak Blood Flow Data
Pre CUFF Testing Flows Female

	
  

Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

2

22.22519733

404.5078673

3

20.35982427

382.7482208

4

23.99261081

220.9790071

5

47.81266657

570.7514923

6

73.14511132

366.1467813

7

18.4721024

279.9516878

8

21.63822891

709.7212716
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Pre EIHG Testing Flows Female
Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

2

14.60205232

205.5673214

3

19.59163852

434.3219139

4

28.77236416

581.7644794

5

48.13869258

847.6186324

6

31.1149305

413.5066312

7

28.10489987

304.8371524

8

68.35749489

460.7339396

Pre NEIHG Testing Flows Female

	
  

Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

2

22.29328193

425.2542218

3

21.63324871

376.0325289

4

25.33594238

403.88686

5

45.90914855

561.0371047

6

53.16600149

265.6374032

7

18.11859245

391.7234726

8

49.63268045

535.50808
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Post CUFF Testing Flows Female
Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

2

17.73813899

270.1877329

3

21.42480324

356.5324867

4

20.83494608

327.5638129

5

23.27570226

435.5061611

6

91.06042693

528.5279628

7

19.57201412

320.3457525

8

25.25685597

424.5895606

Post EIHG Testing Flows Female

	
  

Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

2

56.16773976

246.2693679

3

33.79627911

377.0957874

4

22.34190045

605.5760602

5

27.60999991

624.277575

6

41.10740014

416.1127884

7

27.95703032

368.7801058

8

46.62203405

487.0128601
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Post NEIHG Testing Flows Female
Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

2

17.11948178

257.0308573

3

26.2993078

482.7056463

4

18.87184917

313.8152303

5

30.25820127

728.2940992

6

25.25452248

477.5617903

7

21.06789363

375.2653923

8

37.44781531

661.9019017

Pre CUFF Testing Flows Male
Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

1

188.0804487

1054.058321

Pre EIHG Testing Flows Male
Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

1

217.2368179

1072.10085

Pre NEIHG Testing Flows Male
Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

1

68.0977749

967.7796548

Post CUFF Testing Flows Male

	
  

Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

1

123.6441267

1114.223419
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Post EIHG Testing Flows Male
Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

1

168.586634

964.9555118

Post NEIHG Testing Flows Male
Participant

Resting Flow (cm/s)

Peak Flow (cm/s)

1

102.3508548

733.0389512

Resting Diameter, Peak Diameter, and Flow-Mediated Dilation Data
Pre CUFF Testing FMD Female

	
  

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

2

2.3242

2.858

0.5338

22.96704242

3

2.6812

2.8473

0.1661

6.194987319

4

2.8376

2.926

0.0884

3.115308712

5

3.4228

3.8877

0.4649

13.58244712

6

2.9678

3.2867

0.3189

10.74533324

7

2.9076

3.0443

0.1367

4.701472004

8

3.1154

3.5743

0.4589

14.73005072
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Pre EIHG Testing FMD Female

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

2

2.1224

2.5393

0.4169

19.64285714

3

2.6128

2.9745

0.3617

13.84338641

4

2.8872

3.9437

1.0565

36.59254641

5

3.4878

4.8547

1.3669

39.19089397

6

3.1057

3.2863

0.1806

5.815114145

7

2.9293

3.21

0.2807

9.582494111

8

3.4487

3.4605

0.0118

0.342157915

Pre NEIHG Testing FMD Female

	
  

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

2

2.9457

3.3747

0.429

14.56360118

3

2.7104

3.5517

0.8413

17.20410272

4

2.9095

3.3167

0.4072

13.99553188

5

3.9078

3.988

0.0802

2.052305645

6

3.03675

3.095

0.05825

0.019181691

7

2.8101

3.0547

0.2446

8.704316572

8

3.362

3.4393

0.0773

2.299226651
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Post CUFF Testing FMD Female

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

2

2.3633

2.9017

0.5384

22.78170355

3

2.7064

2.8693

0.1629

6.019065918

4

2.7724

3

0.2276

8.20949358

5

3.4544

3.701

0.2466

7.13872163

6

2.8989

3.3313

0.4324

14.91600262

7

2.7911

2.8907

0.0996

3.568485543

8

3.4373

3.1407

-0.2966

-8.628865679

Post EIHG Testing FMD Female

	
  

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

2

2.5347

2.4783

-0.0564

-2.225115398

3

2.6277

2.8103

0.1826

6.949042889

4

2.7241

3.7595

1.0354

38.00888367

5

3.3155

4.0787

0.7632

23.01915247

6

3.0084

3.4393

0.4309

14.32322829

7

2.9966

3.1883

0.1917

6.397250217

8

3.2932

3.515

0.2218

6.735090489
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Post NEIHG Testing FMD Female

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

2

2.817

2.9943

0.1773

6.293929712

3

2.7487

3.0203

0.2716

9.881034671

4

2.9071

3.1957

0.2886

9.927419077

5

3.7906

3.8293

0.0387

1.020946552

6

3.1089

3.2127

0.1038

3.338801505

7

2.7402

3.199

0.4588

16.74330341

8

3.2487

3.476

0.2273

6.996644812

Pre CUFF Testing FMD Male

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

1

4.9424

4.942

-0.0004

-0.008093234

Pre EIHG Testing FMD Male

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

1

5.0536

4.8643

-0.1893

-3.745844546

Pre NEIHG Testing FMD Male

	
  

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

1

5.0748

5.143

0.0682

1.343895326
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Post CUFF Testing FMD Male

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

1

4.7075

5.1787

0.4712

10.00955921

Post EIHG Testing FMD Male

Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

1

4.7855

5.5133

0.7278

15.20844217

Post NEIHG Testing FMD Male
Participant

Resting Diameter
(mm)

Peak Diameter
(mm)

FMD Absolute
(mm)

Non-Normalized
FMD Relative
(%)

1

5.3078

4.951

-0.3568

-6.722182448

Resting and Peak Shear Data
Pre CUFF Shear Flows Female
Participant Resting Shear (s-1) Peak Shear (s-1)
2
30.05204222
361.7244643
3
17.93226913
298.9278434
4
17.82677726
154.4187576
5
20.24171244
187.2961708
6
47.5040097
193.887279
7
12.75737149
176.3690558
8
12.14868075
302.719822
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Pre EIHG Testing Shear Female
Participant Resting Shear (s-1) Peak Shear (s-1)
2
25.92871801
255.0043975
3
18.64666258
318.9528475
4
20.29522154
219.9436594
5
19.26142554
175.05438
6
17.63352688
209.2943083
7
18.98188522
171.4521103
8
28.29233181
189.3938779
Pre NEIHG Testing Shear Female
Participant Resting Shear (s-1) Peak Shear (s-1)
2
14.80666735
215.1981985
3
18.44465059
233.3933491
4
17.4634817
214.2287907
5
13.0602385
153.2490574
6
32.22966073
155.0271398
7
13.86142842
253.6118525
8
22.172949
228.6004362
Post CUFF Shear Flows Female
Participant Resting Shear (s-1) Peak Shear (s-1)
2
22.81394257
230.5104444
3
18.34804273
271.6464676
4
16.5986805
222.8673111
5
9.585919407
156.2544388
6
63.45689744
278.9048721
7
15.28122553
233.1773614
8
10.55785829
212.5924417
	
  
	
  
Post EIHG Shear Flows Female
Participant Resting Shear (s-1) Peak Shear (s-1)
2
58.55393801
268.5498613
3
31.62207761
308.4745848
4
18.76289417
267.0141821
5
12.86080531
192.1471875
6
25.63079787
198.5108363
7
17.63817175
205.527153
8
22.16081623
203.1985101
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Post NEIHG Shear Flows Female
Participant Resting Shear (s-1) Peak Shear (s-1)
2
13.00106496
172.7653532
3
21.49864785
326.8163132
4
13.04017437
179.4448075
5
9.431224608
222.4379606
6
14.268153
252.6569955
7
17.38293821
227.1834173
8
18.54157047
286.2683535

Normalized Flow-Mediated Dilation to Area-Under-Curve Data
Normalized FMD Pre CUFF Female

	
  

Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

2

5812.3165

22.96704242

3.951443873

3

5031.7688

6.194987319

1.231174874

4

430.9138

3.115308712

7.229540367

5

3938.7774

13.58244712

3.448391656

6

2956.0875

10.74533324

3.634984838

7

2859.1754

4.701472004

1.644345431

8

9186.8551

14.73005072

1.603383373
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Normalized FMD Pre EIHG Female
Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

2

1892.3211

19.64285714

10.38029811

3

7845.7111

13.84338641

1.764452735

4

4164.2788

36.59254641

8.787247005

5

979.6796

10.5195252

10.73771997

6

5102.4433

5.815114145

1.139672467

7

3102.5985

9.582494111

3.08853824

8

6153.2461

0.342157915

0.055606083

Normalized FMD Pre NEIHG Female

	
  

Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

2

679.2549

14.56360118

21.44055373

3

1597.6749

17.20410272

10.76821243

4

3096.7299

13.99553188

4.519455145

5

2118.9745

2.052305645

0.968537208

6

225.3807

0.019181691

0.085107957

7

754.1978

8.704316572

11.54115879

8

8992.5004

2.299226651

0.255682685
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Normalized FMD Post CUFF Female
Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

2

2835.0948

22.78170355

8.035605564

3

1759.0219

6.019065918

3.421825458

4

2842.9362

8.20949358

2.887681257

5

1076.4615

7.13872163

6.631655317

6

8317.5512

14.91600262

1.793316598

7

2480.3568

8.54860091

3.446520642

8

4438.903

-5.419951706

-1.221011522

Normalized FMD Post EIHG Female

	
  

Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

2

5623.3676

-2.225115398

-0.395690902

3

9017.9755

6.949042889

0.770576821

4

3862.8437

38.00888367

9.839612115

5

3641.2896

23.01915247

6.321703296

6

1929.4074

14.32322829

7.423641214

7

2495.8424

6.397250217

2.563162729

8

4346.8623

6.735090489

1.549414273
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Normalized FMD Post NEIHG Female
Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

2

1987.3845

6.293929712

3.166941129

3

6375.3274

9.881034671

1.549886626

4

3230.7513

9.927419077

3.072789626

5

1927.8325

1.020946552

0.529582602

6

2350.3771

3.338801505

1.420538647

7

2370.1924

16.74330341

7.064111508

8

4763.426

6.996644812

1.468826179

Normalized FMD Pre CUFF Male
Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

1

4360.5706

-0.008093234

-0.001856003

Normalized FMD Pre EIHG Male
Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

1

1814.5938

-3.745844546

-2.064288188

Normalized FMD Pre NEIHG Male

	
  

Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

1

3498.6218

1.343895326

0.384121349
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Normalized FMD Post CUFF Male
Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

1

2319.6843

10.00955921

4.31505236

Normalized FMD Post EIHG Male
Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

1

2691.0906

15.20844217

5.651404739

Normalized FMD Post NEIHG Male
Participant

AUC (s^1)

FMD (%
Change)

Normalized FMD
(FMD:AUC)

1

2133.3905

-6.722182448

-3.150938587

Resistance Vessel Function Plethysmography Data

Pre NEIHG (ml/min/100mL)

	
  

Participant

Pre1

Pre2

Pre3

PreAVG

Post

1
2

NA
NA

NA
NA

NA
NA

NA
NA

NA
NA

3
4
5
6
7
8

11.80039
0.84006
3.31918
8.29485
4.48572
8.6471

18.5501
1.93445
3.90108
6.02313
8.80818
7.29131

12.04631
1.63782
3.45281
3.05427
7.40931
5.1879

14.13226667
1.470776667
3.55769
5.79075
6.90107
7.042103333

47.09532
5.82215
43.17275
39.6503
28.40552
41.76925
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Pre EIHG (ml/min/100mL)
Participant

Pre1

Pre2

Pre3

PreAVG

Post

1
2

NA
NA

NA
NA

NA
NA

NA
NA

NA
NA

3
4
5
6
7
8

20.2617
6.01138
14.72074
13.01243
7.54566
5.2134

42.9035
6.4931
10.00891
9.7227
5.73339
6.32424

32.82851
5.82604
10.02425
5.40492
4.1882
2.85904

31.99790333
6.110173333
11.58463333
9.380016667
5.822416667
4.798893333

66.83889
26.12393
77.38969
45.4065
26.28721
50.08815

Pre CUFF (ml/min/100mL)
Participant

Pre1

Pre2

Pre3

PreAVG

Post

1

NA

NA

NA

NA

NA

2

3.32829
2.24736
7.45178
7.68731
5.06635
2.44427
2.89552

2.64789
2.10095
10.1916
4.95402
3.86301
1.94474
2.57575

1.74952
1.65911
9.57748
6.7541
5.13548
2.53613
3.27492

2.575233333
2.002473333
9.07362
6.465143333
4.68828
2.30838
2.915396667

38.10101
46.1206
23.05956
46.33809
45.69986
41.53496
34.83446

3
4
5
6
7
8

Post NEIHG (ml/min/100mL)

	
  

Participant

Pre1

Pre2

Pre3

PreAVG

Post

1
2

NA
NA

NA
NA

NA
NA

NA
NA

NA
NA

3
4
5
6
7
8

4.70431
4.321385
10.72153
2.7511
1.29277
7.52166

6.96192
4.082782
10.64342
3.57957
4.07373
6.67188

7.93385
1.640562
13.5788
2.89176
4.66594
6.1386

6.53336
3.348243
11.64792
3.074143333
3.344146667
6.77738

58.8782
35.80695
106.1506
43.05418
32.47578
33.91461

138	
  

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

Post EIHG (ml/min/100mL)
Participant

Pre1

Pre2

Pre3

PreAVG

Post

1
2

NA
NA

NA
NA

NA
NA

NA
NA

NA
NA

3
4
5
6
7
8

17.55736
10.10476
7.60458
12.73225
7.5286
10.70901

12.71173
12.93273
8.81746
22.50849
8.23375
11.0428

8.84376
12.70704
9.41001
9.72716
8.23236
12.142

13.03761667
11.91484333
8.610683333
14.9893
7.998236667
11.29793667

53.45543
31.34942
70.57919
23.19122
40.37915
50.67992

Post CUFF (ml/min/100mL)
Participant

Pre1

Pre2

Pre3

PreAVG

Post

1
2

NA

NA

NA

NA

NA

2.74114
3.2693
19.0933
15.25128
5.1017
1.77377
0.94592

2.61477
3.9803
12.4226
14.48485
6.77356
1.88094
8.32322

1.8213
5.45247
14.5353
12.56437
4.39923
2.0721
9.2521

2.392403333
4.234023333
15.3504
14.10016667
5.42483
1.908936667
6.173746667

32.99766
39.13814
28.83334
76.01387
52.4203
27.34554
66.09124

3
4
5
6
7
8

*All missing data for participant 1 and 2 was due to equipment malfunction at the time of
testing.
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Appendix P: Statistics for Chapter 2
Resting SBP
One Way Repeated Measures Analysis of Variance
Data source: Data 1 in Resting SBP.JNB
Normality Test (Shapiro-Wilk) Passed (P = 0.100)
Equal Variance Test:
Passed (P = 0.466)
Treatment Name
Rest IV
Rest Fam
Rest CUFF
Rest EIHG
Rest NEIHG

N
7
7
7
7
7

Source of Variation
Between Subjects
Between Treatments
Residual
Total

Missing
0
0
0
0
0
DF
6
4
24
34

Mean
102.333
105.667
99.381
96.476
98.286

SS
1410.394
366.635
1326.432
3103.460

Monday, October 21, 2013

Std Dev
4.907
13.894
10.783
6.960
8.620
MS
235.066
91.659
55.268

SEM
1.854
5.251
4.076
2.631
3.258
F

P

1.658

0.192

Power of performed test with alpha = 0.050: 0.181

Resting DBP
One Way Repeated Measures Analysis of Variance
Data source: Data 1 in Resting DBP.JNB
Normality Test (Shapiro-Wilk) Passed (P = 0.388)
Equal Variance Test:
Passed (P = 0.252)
Treatment Name
Rest IV
Rest Fam
Rest CUFF
Rest EIHG
REST NEIHG
Source of Variation
Between Subjects
Between Treatments
Residual
Total

N
7
7
7
7
7

Missing
0
0
0
0
0
DF
6
4
24
34

Mean
60.619
62.714
59.952
59.667
59.095

SS
317.263
54.908
304.292
676.463

Std Dev
4.143
4.633
3.325
5.168
5.216
MS
52.877
13.727
12.679

Power of performed test with alpha = 0.050: 0.063
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SEM
1.566
1.751
1.257
1.953
1.972
F

P

1.083

0.387

M.H.K. Thesis – J. Seifarth

University of Windsor – Applied Human Performance

Resting MAP
One Way Repeated Measures Analysis of Variance
Data source: Data 1 in Resting MAP.JNB
Normality Test (Shapiro-Wilk) Passed (P = 0.742)
Equal Variance Test:
Passed (P = 0.688)
Treatment Name
Rest IV
Rest Fam
Rest CUFF
Rest EIHG
REST NEIHG

N
7
7
7
7
7

Source of Variation
Between Subjects
Between Treatments
Residual
Total

Missing
0
0
0
0
0
DF
6
4
24
34

Mean
74.524
77.032
73.095
71.937
72.159

SS
478.018
123.328
363.971
965.317

Monday, October 21, 2013

Std Dev
3.722
6.417
5.666
4.437
5.789
MS
79.670
30.832
15.165

SEM
1.407
2.425
2.142
1.677
2.188
F

P

2.033

0.122

Power of performed test with alpha = 0.050: 0.270

Resting HR
One Way Repeated Measures Analysis of Variance
Data source: Data 1 in Resting HR.JNB
Normality Test (Shapiro-Wilk) Passed (P = 0.278)
Equal Variance Test:
Passed (P = 0.669)
Treatment Name
Rest IV
Rest Fam
Rest CUFF
Rest EIHG
REST NEIHG
Source of Variation
Between Subjects
Between Treatments
Residual
Total

N
7
7
7
7
7

Missing
0
0
0
0
0
DF
6
4
24
34

Mean
70.286
68.429
69.286
68.619
68.524

SS
584.083
17.003
390.552
991.638

Std Dev
5.342
5.862
5.522
6.057
5.689
MS
97.347
4.251
16.273

Power of performed test with alpha = 0.050: 0.050
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SEM
2.019
2.216
2.087
2.289
2.150
F

P

0.261

0.900
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Resting BA Diameter
Two Way Repeated Measures ANOVA (Two Factor Repetition)
Data source: Data 1 in Resting Diameters.JNB
Balanced Design
Dependent Variable: Resting Diameter
Normality Test (Shapiro-Wilk) Passed (P = 0.932)
Equal Variance Test:
Passed (P = 0.994)
Source of Variation
Participant
Day
Day x Participant
Pre-Post
Pre-Post x Participant
Day x Pre-Post
Residual
Total

DF
6
2
12
1
6
2
12
41

SS
4.749
0.228
0.511
0.00146
0.0412
0.00853
0.173
5.712

MS
0.792
0.114
0.0426
0.00146
0.00686
0.00426
0.0144
0.139

Monday, October 21, 2013

F

P

2.671

0.110

0.213

0.661

0.295

0.749

Power of performed test with alpha = 0.0500: for Day : 0.276
Power of performed test with alpha = 0.0500: for Pre-Post : 0.0500
Power of performed test with alpha = 0.0500: for Day x Pre-Post : 0.0500
Least square means for Day :
Group Mean
CUFF
2.906
EIHG
2.935
NEIHG 3.075
Std Err of LS Mean = 0.0551
Least square means for Pre-Post :
Group Mean
Pre
2.978
Post
2.966
Std Err of LS Mean = 0.0181
Least square means for Day x Pre-Post :
Group
Mean
CUFF x Pre
2.894
CUFF x Post
2.918
EIHG x Pre
2.942
EIHG x Post
2.929
NEIHG x Pre
3.097
NEIHG x Post 3.052
Std Err of LS Mean = 0.0454
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Resting Mean Blood Flow
Two Way Repeated Measures ANOVA (Two Factor Repetition)
Data source: Data 1 in Resting Flows.JNB
Balanced Design
Dependent Variable: Resting Flow
Normality Test (Shapiro-Wilk) Passed (P = 0.968)
Equal Variance Test:
Passed (P = 0.998)
Source of Variation
Participant
Day
Day x Participant
Pre-Post
Pre-Post x Participant
Day x Pre-Post
Residual
Total

DF
6
2
12
1
6
2
12
41

SS
4926.916
241.455
4053.200
62.738
986.085
218.025
1335.461
11823.881

MS
821.153
120.728
337.767
62.738
164.348
109.013
111.288
288.387

Monday, October 21, 2013

F

P

0.357

0.707

0.382

0.559

0.980

0.404

Power of performed test with alpha = 0.0500: for Day : 0.0500
Power of performed test with alpha = 0.0500: for Pre-Post : 0.0500
Power of performed test with alpha = 0.0500: for Day x Pre-Post : 0.0500
Least square means for Day :
Group Mean
CUFF
31.915
EIHG
35.306
NEIHG 29.458
Std Err of LS Mean = 4.912
Least square means for Pre-Post :
Group Mean
Pre
33.448
Post
31.004
Std Err of LS Mean = 2.798
Least square means for Day x Pre-Post :
Group
Mean
CUFF x Pre
32.521
CUFF x Post
31.309
EIHG x Pre
34.097
EIHG x Post
36.515
NEIHG x Pre
33.727
NEIHG x Post 25.188
Std Err of LS Mean = 3.987
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Peak Mean Blood Flow
Two Way Repeated Measures ANOVA (Two Factor Repetition)
Data source: Data 1 in Peak Flows.JNB
Balanced Design
Dependent Variable: Peak Flow
Normality Test (Shapiro-Wilk) Passed (P = 0.529)
Equal Variance Test:
Passed (P = 0.810)
Source of Variation
Participant
Day
Day x Participant
Pre-Post
Pre-Post x Participant
Day x Pre-Post
Residual
Total

DF
6
2
12
1
6
2
12
41

SS
473076.739
24942.395
190008.550
78.128
45699.238
14409.624
117198.136
865412.811

MS
78846.123
12471.198
15834.046
78.128
7616.540
7204.812
9766.511
21107.630

Friday, October 25, 2013

F
0.788

0.477

0.0103

0.923

0.738

0.499

Power of performed test with alpha = 0.0500: for Day : 0.0500
Power of performed test with alpha = 0.0500: for Pre-Post : 0.0500
Power of performed test with alpha = 0.0500: for Day x Pre-Post : 0.0500
Least square means for Day :
Group Mean
CUFF
399.861
EIHG
455.248
NEIHG 446.832
Std Err of LS Mean = 33.630
Least square means for Pre-Post :
Group Mean
Pre
435.345
Post
432.617
Std Err of LS Mean = 19.044
Least square means for Day x Pre-Post :
Group
Mean
CUFF x Pre
419.258
CUFF x Post
380.465
EIHG x Pre
464.050
EIHG x Post
446.446
NEIHG x Pre
422.726
NEIHG x Post 470.939
Std Err of LS Mean = 37.353
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Resting Shear Rate
Two Way Repeated Measures ANOVA (Two Factor Repetition)
Data source: Data 1 in Notebook1
Balanced Design
Dependent Variable: Resting Shear
Normality Test (Shapiro-Wilk) Passed (P = 0.468)
Equal Variance Test:
Passed (P = 1.000)
Source of Variation
Participant
Day
Day x Participant
Pre-Post
Pre-Post x Participant
Day x Pre-Post
Residual
Total

DF
6
2
12
1
6
2
12
41

SS
1728.506
372.167
2205.789
3.146
245.671
145.465
707.707
5408.451

MS
288.084
186.083
183.816
3.146
40.945
72.733
58.976
131.913

F

Least square means for Pre-Post :
Group Mean
Pre
20.931
Post
21.478
Std Err of LS Mean = 1.396
Least square means for Day x Pre-Post :
Group
Mean
CUFF x Pre
22.638
CUFF x Post
22.378
EIHG x Pre
21.291
EIHG x Post
26.747
NEIHG x Pre
18.863
NEIHG x Post 15.309
Std Err of LS Mean = 2.903
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P

1.012

0.392

0.0768

0.791

1.233

0.326

Power of performed test with alpha = 0.0500: for Day : 0.0508
Power of performed test with alpha = 0.0500: for Pre-Post : 0.0500
Power of performed test with alpha = 0.0500: for Day x Pre-Post : 0.0772
Least square means for Day :
Group Mean
CUFF
22.508
EIHG
24.019
NEIHG 17.086
Std Err of LS Mean = 3.623

Friday, November 01, 2013
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Peak Shear Rate
Two Way Repeated Measures ANOVA (Two Factor Repetition)
Data source: Data 1 in Notebook1
Balanced Design
Dependent Variable: Peak Shear
Normality Test (Shapiro-Wilk) Failed (P < 0.050)
Equal Variance Test:
Passed (P = 0.854)
Source of Variation
Participant
Day
Day x Participant
Time
Time x Participant
Day x Time
Residual
Total

DF
6
2
12
1
6
2
12
41

SS
46928.172
935.455
24187.570
1478.599
10578.091
2921.992
23290.520
110320.399

MS
7821.362
467.728
2015.631
1478.599
1763.015
1460.996
1940.877
2690.741

Friday, November 01, 2013

F

P

0.232

0.796

0.839

0.395

0.753

0.492

Power of performed test with alpha = 0.0500: for Day : 0.0500
Power of performed test with alpha = 0.0500: for Time : 0.0500
Power of performed test with alpha = 0.0500: for Day x Time : 0.0500
Least square means for Day :
Group Mean
CUFF
234.378
EIHG
227.323
NEIHG 222.920
Std Err of LS Mean = 11.999
Least square means for Time :
Group Mean
Pre
222.274
Post
234.140
Std Err of LS Mean = 9.163
Least square means for Day x Time :
Group
Mean
CUFF x Pre
239.335
CUFF x Post
229.422
EIHG x Pre
219.871
EIHG x Post
234.775
NEIHG x Pre
207.616
NEIHG x Post 238.225
Std Err of LS Mean = 16.651	
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Non-Normalized FMD (% Change)
Two Way Repeated Measures ANOVA (Two Factor Repetition)
Data source: Data 1 in Non-Normalized FMD.JNB
Balanced Design
Dependent Variable: FMD %Change
Normality Test (Shapiro-Wilk) Passed (P = 1.000)
Equal Variance Test:
Passed (P = 0.569)
Source of Variation
Subject
Day
Day x Subject
PrePost
PrePost x Subject
Day x PrePost
Residual
Total

DF
6
2
12
1
6
2
12
41

SS
721.807
217.163
1610.924
11.119
250.814
4.805
508.505
3325.136

MS
120.301
108.582
134.244
11.119
41.802
2.402
42.375
81.101

Friday, October 25, 2013

F
0.809

0.468

0.266

0.624

0.0567

0.945

Power of performed test with alpha = 0.0500: for Day : 0.0500
Power of performed test with alpha = 0.0500: for PrePost : 0.0500
Power of performed test with alpha = 0.0500: for Day x PrePost : 0.0500
Least square means for Day :
Group Mean
CUFF
9.874
EIHG
13.539
NEIHG 8.074
Std Err of LS Mean = 3.097
Least square means for PrePost :
Group Mean
Pre
11.010
Post
9.981
Std Err of LS Mean = 1.411
Least square means for Day x PrePost :
Group
Mean
CUFF x Pre
10.862
CUFF x Post
8.885
EIHG x Pre
13.763
EIHG x Post
13.315
NEIHG x Pre
8.405
NEIHG x Post
7.743
Std Err of LS Mean = 2.460
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Normalized FMD (FMD:AUC)
Two Way Repeated Measures ANOVA (Two Factor Repetition)
Data source: Data 1 in Normalized FMD.JNB
Balanced Design
Dependent Variable: FMDnorm
Normality Test (Shapiro-Wilk) Passed (P = 0.998)
Equal Variance Test:
Passed (P = 0.447)
Source of Variation
Participant
Time
Time x Participant
Day
Day x Participant
Time x Day
Residual
Total

DF
6
1
6
2
12
2
12
41

SS
199.489
32.480
93.600
16.296
238.740
42.323
176.238
799.166

MS
33.248
32.480
15.600
8.148
19.895
21.162
14.686
19.492

F

P

2.082

0.199

0.410

0.673

1.441

0.275

Power of performed test with alpha = 0.0500: for Time : 0.137
Power of performed test with alpha = 0.0500: for Day : 0.0500
Power of performed test with alpha = 0.0500: for Time x Day : 0.103
Least square means for Time :
Group Mean
Pre
5.156
Post
3.397
Std Err of LS Mean = 0.862
Least square means for Day :
Group Mean
CUFF
3.410
EIHG
4.573
NEIHG 4.847
Std Err of LS Mean = 1.192
Least square means for Time x Day :
Group
Mean
Pre x CUFF
3.249
Pre x EIHG
5.136
Pre x NEIHG
7.083
Post x CUFF
3.571
Post x EIHG
4.010
Post x NEIHG 2.610
Std Err of LS Mean = 1.448
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RVF (% Change)
Two Way Repeated Measures ANOVA (Two Factor Repetition)
Data source: Data 1 in Plethysmography.JNB
General Linear Model
Dependent Variable: % Change
The following subject was deleted from calculations because of missing data: 2
Normality Test (Shapiro-Wilk) Passed (P = 0.997)
Equal Variance Test:
Passed (P = 0.997)

Friday, October 25, 2013

Source of Variation
Participant
Day
Day x Participant
Pre-Post
Pre-Post x Participant
Day x Pre-Post
Residual
Total

F
0.741
2.876

P
0.624
0.103

0.266

0.628

3.407

0.074

DF
5
2
10
1
5
2
10
35

SS
886899.241
1752817.802
3046818.347
12967.762
243483.085
776468.553
1139471.415
7858926.206

MS
177379.848
876408.901
304681.835
12967.762
48696.617
388234.277
113947.141
224540.749

Power of performed test with alpha = 0.0500: for Day : 0.294
Power of performed test with alpha = 0.0500: for Pre-Post : 0.0500
Power of performed test with alpha = 0.0500: for Day x Pre-Post : 0.368
Expected Mean Squares:
Approximate DF Residual for Day = 10.000
Approximate DF Residual for Pre-Post = 5.000
Approximate DF Residual for Participant = 5.185
Expected MS(Day) = var(res) + 2.000 var(Day x Participant) + var(Day)
Expected MS(Pre-Post) = var(res) + 3.000 var(Pre-Post x Participant) + var(Pre-Post)
Expected MS(Participant) = var(res) + 2.000 var(Day x Participant) +3.000 var(Pre-Post x Participant)
+6.000 var(Participant)
Expected MS(Day x Participant) = var(res) + 2.000 var(Day x Participant)
Expected MS(Day x Pre-Post) = var(res) + var(Day x Pre-Post)
Expected MS(Pre-Post x Participant) = var(res) + 3.000 var(Pre-Post x Participant)
Expected MS(Residual) = var(res)
Least square means for Day :
Group Mean
SEM
NEIHG 682.173
159.343
EIHG
390.393
159.343
CUFF
930.301
159.343
Least square means for Pre-Post :
Group Mean
SEM
Pre
686.602
52.013
Post
648.643
52.013
Least square means for Day x Pre-Post :
Group
Mean
SEM
NEIHG x Pre
505.345
137.809
NEIHG x Post
859.001
137.809
EIHG x Pre
447.296
137.809
EIHG x Post
333.490
137.809
CUFF x Pre
1107.164
137.809
CUFF x Post
753.438 137.809
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Correlations between FMD and AUC
Pre CUFF
Pearson Product Moment Correlation
Data source: Data 1 in Pre Cuff Correlation.JNB
Cell Contents:
Correlation Coefficient
P Value
Number of Samples
Shear

Tuesday, November 05, 2013

FMD
0.625
0.133
7

Post CUFF
Pearson Product Moment Correlation
Data source: Data 1 in Notebook1

Tuesday, November 05, 2013

Cell Contents:
Correlation Coefficient
P Value
Number of Samples
Shear

FMD
0.132
0.779
7

Pre EIHG
Pearson Product Moment Correlation
Data source: Data 1 in Notebook1
Cell Contents:
Correlation Coefficient
P Value
Number of Samples
Shear

Tuesday, November 05, 2013

FMD
-0.191
0.681
7

Post EIHG
Pearson Product Moment Correlation
Data source: Data 1 in Notebook1
Cell Contents:
Correlation Coefficient
P Value
Number of Samples
Shear

	
  

Tuesday, November 05, 2013

FMD
-0.306
0.505
7
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Pre NEIHG
Pearson Product Moment Correlation
Data source: Data 1 in Notebook1
Cell Contents:
Correlation Coefficient
P Value
Number of Samples

Tuesday, November 05, 2013

FMD
SHEAR -0.271
0.557
7

Post NEIHG
Pearson Product Moment Correlation
Data source: Data 1 in Notebook1
Cell Contents:
Correlation Coefficient
P Value
Number of Samples

Tuesday, November 05, 2013

FMD
SHEAR 0.237
0.608
7

Correlations of FMD between EIHG and CUFF Testing Days
Pearson Product Moment Correlation
Data source: Data 1 in Non-Normalized FMD.JNB

Wednesday, November 20, 2013

Cell Contents:
Correlation Coefficient
P Value
Number of Samples
CUFF Pre

EIHG Pre
-0.287
0.533

7
Pearson Product Moment Correlation

Wednesday, November 20, 2013

Cell Contents:
Correlation Coefficient
P Value
Number of Samples
CUFF Pre

EIHG Pre
-0.346
0.502

6
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Appendix Q: Reproducibility

Inter-Observer Reproducibility
ID
2
3
4
5
6
7
8
2
3
4
5
6
7
8

	
  

	
  

Testing Day
Pre CUFF
Pre CUFF
Pre CUFF
Pre CUFF
Pre CUFF
Pre CUFF
Pre CUFF
Post CUFF
Post CUFF
Post CUFF
Post CUFF
Post CUFF
Post CUFF
Post CUFF

	
  

Investigator 1
2.32
2.68
2.84
3.42
2.97
2.91
3.12
2.36
2.71
2.77
3.45
2.90
2.79
3.44

	
  

Investigator 2
2.21
2.73
2.73
3.32
3.09
2.93
3.11
2.20
2.76
2.77
3.47
2.87
2.65
3.27
CC
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X
2.27
2.71
2.78
3.37
3.03
2.92
3.11
2.28
2.73
2.77
3.46
2.88
2.72
3.35
0.97
	
  

SD
0.08
0.04
0.08
0.07
0.09
0.02
0.01
0.11
0.04
0.00
0.01
0.02
0.10
0.12
Cv

Cv
3.53
1.36
2.73
2.20
2.94
0.60
0.22
4.97
1.30
0.10
0.37
0.81
3.55
3.53
2.01
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Method Error
ID
Testing Day
2
Pre CUFF
3
Pre CUFF
4
Pre CUFF
5
Pre CUFF
6
Pre CUFF
7
Pre CUFF
8
Pre CUFF
2
Post CUFF
3
Post CUFF
4
Post CUFF
5
Post CUFF
6
Post CUFF
7
Post CUFF
8
Post CUFF
2
3
4
5
6
7
8
2
3
4
5
6
7
8
Grand Mean
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Investigator 1
2.32
2.68
2.84
3.42
2.97
2.91
3.12
2.36
2.71
2.77
3.45
2.90
2.79
3.44
2.21
2.73
2.73
3.32
3.09
2.93
3.11
2.20
2.76
2.77
3.47
2.87
2.65
3.27
2.89

Investigator 2
2.21
2.73
2.73
3.32
3.09
2.93
3.11
2.20
2.76
2.77
3.47
2.87
2.65
3.27

Mean Difference
SD Difference
Method Error
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Difference
0.11
-0.05
0.11
0.10
-0.13
-0.02
0.01
0.16
-0.05
0.00
-0.02
0.03
0.14
0.17

0.04
0.09
3.16
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Intra-Observer Reproducibility
ID
2
3
4
5
6
7
8

ID
2
3
4
5
6
7
8
2
3
4
5
6
7
8

CUFF
2.3242
2.6812
2.8376
3.4228
2.9678
2.9076
3.1154

	
  
	
  

CUFF
2.3242
2.6812
2.8376
3.4228
2.9678
2.9076
3.1154
2.1224
2.6128
2.8872
3.4878
3.1057
2.9293
3.4487
Grand Mean

EIHG
2.1224
2.6128
2.8872
3.4878
3.1057
2.9293
3.4487
CC
	
  
	
  

	
  
	
  
	
  
	
  
	
  
	
  
	
  

X
2.22
2.65
2.86
3.46
3.04
2.92
3.28
0.97
	
  
	
  

EIHG
2.1224
2.6128
2.8872
3.4878
3.1057
2.9293
3.4487

	
  
	
  
	
  
	
  
	
  
	
  
	
   Mean Difference

2.92

	
  
	
  
	
  

SD Difference
Method Error

	
  
	
  
	
  

	
  

Difference
0.2018
0.0684
-0.0496
-0.065
-0.1379
-0.0217
-0.3333
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SD
0.14
0.05
0.04
0.05
0.10
0.02
0.24
Cv

Cv
6.41812389
1.827204527
1.225282852
1.330186692
3.210999428
0.525765977
7.180837896
3.102628752

	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
   -0.05

	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

0.17
5.71
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Appendix R: Vascular Function Scatter Plots

CUFF FMD
25

Relative FMD (% change)

20
15
10
5
0
-5
-10

Pre

Post

EIHG FMD
45
40

Relative FMD (% change)

35
30
25
20
15
10
5
0
-5

	
  

Post

Pre
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NEIHG FMD
20
18

Relative FMD (% change)

16
14
12
10
8
6
4
2
0

Pre

Post

CUFF RVF
2500

Relative FMD (% change)

2000

1500

1000

500

0

Pre

	
  

Post
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EIHG RVF
1000
900

Relative FMD (% change)

800
700
600
500
400
300
200
100
0

Pre

Post

NEIHG RVF
1400

Relative FMD (% change)

1200
1000
800
600
400
200
0

Pre

	
  

Post
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